Multiple	O
NF-ATc	B-protein
isoforms	I-protein
with	O
individual	O
transcriptional	O
properties	O
are	O
synthesized	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

The	O
transcription	B-protein
factor	I-protein
NF-ATc	B-protein
that	O
controls	O
gene	O
expression	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
and	O
embryonic	B-cell_type
cardiac	I-cell_type
cells	I-cell_type
is	O
expressed	O
in	O
three	O
prominent	O
isoforms	O
.	O

This	O
is	O
due	O
to	O
alternative	O
splice/polyadenylation	O
events	O
that	O
lead	O
to	O
the	O
predominant	O
synthesis	O
of	O
two	O
long	O
isoforms	O
in	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
a	O
shorter	O
NF-ATc	B-protein
isoform	I-protein
in	O
effector	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Whereas	O
the	O
previously	O
described	O
isoform	B-protein
NF-ATc/A	I-protein
contains	O
a	O
relatively	O
short	O
C	B-protein
terminus	I-protein
,	O
the	O
longer	O
isoforms	O
,	O
B	B-protein
and	O
C	B-protein
,	O
span	O
extra	O
C-terminal	O
peptides	O
of	O
128	O
and	O
246	O
aa	O
,	O
respectively	O
.	O

We	O
show	O
here	O
that	O
in	O
addition	O
to	O
the	O
strong	B-protein
N-terminal	I-protein
trans-activation	I-protein
domain	I-protein
,	O
TAD-A	B-protein
,	O
which	O
is	O
common	O
to	O
all	O
three	O
NF-ATc	B-protein
isoforms	I-protein
,	O
NF-ATc/C	B-protein
contains	O
a	O
second	O
trans-activation	B-protein
domain	I-protein
,	O
TAD-B	B-protein
,	O
in	O
its	O
C-terminal	O
peptide	O
.	O

Various	O
stimuli	O
of	O
T	B-cell_type
cells	I-cell_type
that	O
induce	O
the	O
activity	O
of	O
TAD-A	B-protein
also	O
enhance	O
the	O
activity	O
of	O
TAD-B	B-protein
,	O
but	O
,	O
unlike	O
TAD-A	B-protein
,	O
TAD-B	B-protein
remains	O
unphosphorylated	O
by	O
protein	O
from	O
12-O-tetradecanoyl	B-cell_line
12-phorbol	I-cell_line
13-acetate-stimulated	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

The	O
shorter	O
C-terminal	O
peptide	O
of	O
isoform	O
NF-ATc/B	B-protein
exerts	O
a	O
suppressive	O
transcriptional	O
effect	O
.	O

These	O
properties	O
of	O
NF-ATc/B	B-protein
and	I-protein
-C	I-protein
might	O
be	O
of	O
importance	O
for	O
gene	O
regulation	O
in	O
naive	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
in	O
which	O
NF-ATc/B	B-protein
and	I-protein
-C	I-protein
are	O
predominantly	O
synthesized	O
.	O

3	NULL
<	NULL
.	NULL

a	NULL
el	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
g	NULL
The	NULL
film	NULL
”	NULL
)	NULL
!	NULL

keeps	NULL
growing	NULL
Learn	NULL
more	NULL
#	NULL
m	NULL
meJournal	NULL
of	NULL
Multiple	NULL
NF-AT	NULL
c	NULL
Isoforms	NULL
with	NULL
Individual	NULL
Afsﬂlmmunolo	NULL
gy	NULL
Transcriptional	NULL
Properties	NULL
Are	NULL
Synthesized	NULL
in	NULL
T	NULL
Lymphocytes	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Sergei	NULL
Chuvpilo	NULL
,	NULL
Andris	NULL
Avots	NULL
,	NULL
Friederike	NULL
Berberich-Siebelt	NULL
,	NULL
of	NULL
£1	NULL
:	NULL
le	NULL
ggngéigl	NULL
Is	NULL
current	NULL
as	NULL
Judith	NULL
Glockner	NULL
,	NULL
Christian	NULL
Fischer	NULL
,	NULL
Andreas	NULL
Kerstan	NULL
,	NULL
Cornelia	NULL
Escher	NULL
,	NULL
Inna	NULL
Inashkina	NULL
,	NULL
Falk	NULL
Hlubek	NULL
,	NULL
Eriks	NULL
Jankevics	NULL
,	NULL
Thomas	NULL
Brabletz	NULL
and	NULL
Edgar	NULL
Serfling	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162	NULL
;	NULL
:7294-7301	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/12/7294	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
36	NULL
articles	NULL
,	NULL
13	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/12/7294	NULL
.	NULL

full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Multiple	NULL
NF-ATc	NULL
Isoforms	NULL
with	NULL
Individual	NULL
Transcriptional	NULL
Properties	NULL
Are	NULL
Synthesized	NULL
in	NULL
T	NULL
Lymphocytes	NULL
'	NULL
Sergei	NULL
Chuvpilo	NULL
,	NULL
*	NULL
Andris	NULL
Avots	NULL
,	NULL
*	NULL
Friederike	NULL
Berberich-Siebelt	NULL
,	NULL
*	NULL
Judith	NULL
Glockner	NULL
,	NULL
*	NULL
Christian	NULL
Fischer	NULL
,	NULL
*	NULL
Andreas	NULL
Kerstan	NULL
,	NULL
*	NULL
Cornelia	NULL
Escher	NULL
,	NULL
*	NULL
Inna	NULL
Inashkina	NULL
,	NULL
**	NULL
Falk	NULL
Hlubek	NULL
,	NULL
'	NULL
Eriks	NULL
Jankevics	NULL
,	NULL
*	NULL
Thomas	NULL
Brabletz	NULL
,	NULL
'	NULL
and	NULL
Edgar	NULL
Serfling	NULL
``	NULL
*	NULL
The	NULL
transcription	NULL
factor	NULL
NF-A	NULL
Tc	NULL
that	NULL
controls	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
embryonic	NULL
cardiac	NULL
cells	NULL
is	NULL
expressed	NULL
in	NULL
three	NULL
prominent	NULL
isoforms	NULL
.	NULL

This	NULL
is	NULL
due	NULL
to	NULL
alternative	NULL
splice/polyadenylation	NULL
events	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
predominant	NULL
synthesis	NULL
of	NULL
two	NULL
long	NULL
isoforms	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
shorter	NULL
NF-ATc	NULL
isoform	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

Whereas	NULL
the	NULL
previously	NULL
described	NULL
isoform	NULL
NF-ATe/A	NULL
contains	NULL
a	NULL
relatively	NULL
short	NULL
C	NULL
terminus	NULL
,	NULL
the	NULL
longer	NULL
isoforms	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
span	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
of	NULL
128	NULL
and	NULL
246	NULL
aa	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
strong	NULL
N-terminal	NULL
frans-activation	NULL
domain	NULL
,	NULL
TAD-A	NULL
,	NULL
which	NULL
is	NULL
common	NULL
to	NULL
all	NULL
three	NULL
NF-ATe	NULL
isoforms	NULL
,	NULL
NF-ATe/C	NULL
contains	NULL
a	NULL
second	NULL
frans-activation	NULL
domain	NULL
,	NULL
TAD-B	NULL
,	NULL
in	NULL
its	NULL
C-terminal	NULL
peptide	NULL
.	NULL

Various	NULL
stimuli	NULL
of	NULL
T	NULL
cells	NULL
that	NULL
induce	NULL
the	NULL
activity	NULL
of	NULL
TAD-A	NULL
also	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
TAD-B	NULL
,	NULL
but	NULL
,	NULL
unlike	NULL
TAD-A	NULL
,	NULL
TAD-B	NULL
remains	NULL
unphosphorylated	NULL
by	NULL
protein	NULL
from	NULL
12-O-tetradecanoyl	NULL
12-phorbol	NULL
13-acetate-stimulated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
shorter	NULL
C-terminal	NULL
peptide	NULL
of	NULL
isoform	NULL
NF-ATe/B	NULL
exerts	NULL
a	NULL
suppressive	NULL
transcriptional	NULL
effect	NULL
.	NULL

These	NULL
properties	NULL
of	NULL
NF-ATe/B	NULL
and	NULL
-C	NULL
might	NULL
be	NULL
of	NULL
importance	NULL
for	NULL
gene	NULL
regulation	NULL
in	NULL
naive	NULL
T	NULL
lymphocytes	NULL
in	NULL
which	NULL
NF-ATe/B	NULL
and	NULL
-C	NULL
are	NULL
predominantly	NULL
synthesized	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
7294-7301.	NULL
uclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
was	NULL
originally	NULL
deN	NULL
scribed	NULL
as	NULL
a	NULL
nuclear	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
upon	NULL
activation	NULL
of	NULL
Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Multiple	NULL
NF-AT	NULL
binding	NULL
sites	NULL
containing	NULL
the	NULL
core	NULL
sequence	NULL
A/TG-GAAAA	NULL
are	NULL
part	NULL
of	NULL
numerous	NULL
lymphokine	NULL
promoters	NULL
.	NULL

The	NULL
human	NULL
and	NULL
murine	NULL
IL-2	NULL
promoters/enhancers	NULL
harbor	NULL
two	NULL
of	NULL
those	NULL
sites	NULL
to	NULL
which	NULL
NE-AT	NULL
factors	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
2	NULL
)	NULL
and	NULL
several	NULL
low	NULL
affinity	NULL
NF-AT	NULL
binding	NULL
sites	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Multiple	NULL
NF-AT	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
detected	NULL
within	NULL
the	NULL
IL-4	NULL
,	NULL
GM-CSE/IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
TNF-a	NULL
,	NULL
€D40	NULL
ligand	NULL
,	NULL
and	NULL
Fas	NULL
ligand	NULL
promoters/enhancers	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

4	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
NF-AT	NULL
factors	NULL
control	NULL
also	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
further	NULL
pro-	NULL
and	NULL
antiapoptotic	NULL
genes	NULL
,	NULL
genes	NULL
regulating	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
numerous	NULL
transcription	NULL
factor	NULL
genes	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
NF-AT	NULL
factors	NULL
not	NULL
only	NULL
control	NULL
the	NULL
activation	NULL
and	NULL
proliferation	NULL
but	NULL
also	NULL
the	NULL
differentiation	NULL
and	NULL
programmed	NULL
death	NULL
of	NULL
T	NULL
lymphocytes	NULL
as	NULL
well	NULL
as	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

The	NULL
molecular	NULL
cloning	NULL
of	NULL
four	NULL
individual	NULL
NF-AT	NULL
cDNAs	NULL
encoding	NULL
the	NULL
factors	NULL
NF-ATp	NULL
(	NULL
or	NULL
NF-AT1	NULL
)	NULL
,	NULL
NF-ATe	NULL
(	NULL
or	NULL
NF-AT2	NULL
)	NULL
,	NULL
NF-AT3	NULL
,	NULL
and	NULL
NF-AT4	NULL
(	NULL
or	NULL
NF-ATx	NULL
)	NULL
revealed	NULL
several	NULL
common	NULL
structural	NULL
features	NULL
among	NULL
the	NULL
NF-AT	NULL
proteins	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
4	NULL
)	NULL
.	NULL

One	NULL
conspicuous	NULL
structural	NULL
property	NULL
the	NULL
NF-AT	NULL
factors	NULL
share	NULL
with	NULL
Rel/NF-B	NULL
factors	NULL
is	NULL
the	NULL
Rel-like	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
approximately	NULL
300	NULL
aa	NULL
.	NULL

In	NULL
these	NULL
so-called	NULL
Rel	NULL
similarity	NULL
*Department	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Wiirzburg	NULL
,	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
;	NULL
*Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Erlangen-Niimberg	NULL
,	NULL
Er-langen	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
*Biomedical	NULL
Research	NULL
and	NULL
Study	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Latvia	NULL
,	NULL
Riga	NULL
,	NULL
Latvia	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
1	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
6	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Sonderforschungsbereich	NULL
(	NULL
SFB	NULL
)	NULL
465	NULL
(	NULL
Wiirzburg	NULL
)	NULL
and	NULL
SFB	NULL
466	NULL
(	NULL
Erlangen	NULL
)	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
,	NULL
the	NULL
Volkswagen-Stiftung	NULL
,	NULL
and	NULL
the	NULL
Wilhelm	NULL
Sander-Stiftung	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Edgar	NULL
Serfling	NULL
,	NULL
Department	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Wiirzburg	NULL
,	NULL
D-97080	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
path015	NULL
@	NULL
mail.uni-wuerzburg.de	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
domains	NULL
(	NULL
RSDs	NULL
)	NULL
the	NULL
NF-AT	NULL
factors	NULL
exhibit	NULL
>	NULL
60	NULL
%	NULL
homology	NULL
among	NULL
each	NULL
other	NULL
and	NULL
18-20	NULL
%	NULL
homology	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
.	NULL

Several	NULL
segments	NULL
of	NULL
the	NULL
Rel	NULL
similarity	NULL
domain	NULL
from	NULL
NF-ATp	NULL
,	NULL
in	NULL
particular	NULL
an	NULL
octameric	NULL
oligopeptide	NULL
near	NULL
the	NULL
N-terminus	NULL
,	NULL
are	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
corresponding	NULL
DNA	NULL
binding	NULL
motifs	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
(	NULL
7	NULL
)	NULL
,	NULL
which	NULL
is	NULL
reflected	NULL
in	NULL
a	NULL
common	NULL
strand	NULL
topology	NULL
of	NULL
Rel	NULL
domains	NULL
(	NULL
8	NULL
)	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
NF-AT	NULL
and	NULL
NF-KB	NULL
factors	NULL
to	NULL
similar	NULL
DNA	NULL
motifs	NULL
(	NULL
4	NULL
)	NULL
.	NULL

NE-ATp	NULL
and	NULL
NF-ATc	NULL
are	NULL
highly	NULL
expressed	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
and	NULL
strongly	NULL
activate	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
in	NULL
transfection	NULL
assays	NULL
(	NULL
4	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
both	NULL
factors	NULL
play	NULL
a	NULL
very	NULL
similar	NULL
prominent	NULL
role	NULL
in	NULL
gene	NULL
induction	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
inactivation	NULL
of	NULL
the	NULL
NF-ATp	NULL
and	NULL
NF-ATc	NULL
genes	NULL
in	NULL
mice	NULL
resulted	NULL
in	NULL
contrasting	NULL
effects	NULL
on	NULL
cell	NULL
differentiation	NULL
and	NULL
activation	NULL
.	NULL

Inactivation	NULL
of	NULL
the	NULL
NF-ATc	NULL
gene	NULL
led	NULL
to	NULL
severe	NULL
defects	NULL
in	NULL
embryonic	NULL
heart	NULL
development	NULL
and	NULL
to	NULL
the	NULL
early	NULL
death	NULL
of	NULL
embryos	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

NF-ATc	NULL
'~	NULL
thymocytes	NULL
generated	NULL
after	NULL
injection	NULL
of	NULL
NF-ATe	NULL
'~	NULL
ES	NULL
cells	NULL
into	NULL
RAG	NULL
'~	NULL
blastocystes	NULL
showed	NULL
severe	NULL
developmental	NULL
de-fects	NULL
,	NULL
while	NULL
peripheral	NULL
NF-ATc	NULL
'~	NULL
T	NULL
cells	NULL
were	NULL
defective	NULL
in	NULL
their	NULL
proliferation	NULL
and	NULL
the	NULL
production	NULL
of	NULL
Th2	NULL
lymphokines	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NF-ATp	NULL
'~	NULL
mice	NULL
showed	NULL
normal	NULL
heart	NULL
and	NULL
thymus	NULL
de-velopment	NULL
,	NULL
but	NULL
accumulated	NULL
preactivated	NULL
T	NULL
lymphocytes	NULL
(	NULL
13-15	NULL
)	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
Th2	NULL
lymphokines	NULL
and	NULL
Th2-driven	NULL
immune	NULL
responses	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
features	NULL
were	NULL
even	NULL
more	NULL
pronounced	NULL
in	NULL
mice	NULL
double	NULL
deficient	NULL
for	NULL
NF-ATp	NULL
and	NULL
NF-AT4	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
of	NULL
those	NULL
double-deficient	NULL
mice	NULL
produce	NULL
large	NULL
amounts	NULL
of	NULL
the	NULL
Th2-type	NULL
lymphokines	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IL-13	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
NF-ATp	NULL
and	NULL
NF-AT4	NULL
in	NULL
controlling	NULL
a	NULL
major	NULL
repressor	NULL
for	NULL
the	NULL
concerted	NULL
synthesis	NULL
of	NULL
these	NULL
lymphokines	NULL
in	NULL
Th2	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

It	NULL
is	NULL
presently	NULL
unknown	NULL
which	NULL
molecular	NULL
events	NULL
lead	NULL
to	NULL
the	NULL
contrasting	NULL
effects	NULL
of	NULL
NF-AT	NULL
deficiency	NULL
in	NULL
vivo	NULL
.	NULL

Although	NULL
NF-ATp	NULL
and	NULL
-c	NULL
bind	NULL
to	NULL
very	NULL
similar	NULL
,	NULL
if	NULL
not	NULL
identical	NULL
,	NULL
DNA	NULL
motifs	NULL
,	NULL
they	NULL
appear	NULL
to	NULL
control	NULL
quite	NULL
different	NULL
sets	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

One	NULL
mechanism	NULL
leading	NULL
to	NULL
this	NULL
effect	NULL
might	NULL
be	NULL
the	NULL
mode	NULL
of	NULL
NF-AT	NULL
expression	NULL
.	NULL

Contrary	NULL
to	NULL
NF-ATp	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
cardiac	NULL
cells	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
(	NULL
4	NULL
)	NULL
(	NULL
S.	NULL
Chuyvpilo	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
NF-ATe	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
embryonic	NULL
cardiac	NULL
cells	NULL
of	NULL
mice	NULL
,	NULL
where	NULL
it	NULL
controls	NULL
the	NULL
generation	NULL
of	NULL
cardiac	NULL
valves	NULL
and	NULL
septa	NULL
9-12	NULL
days	NULL
after	NULL
gestation	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

While	NULL
NF-ATp	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
several	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
NF-ATc	NULL
is	NULL
inducibly	NULL
expressed	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Another	NULL
mechanism	NULL
leading	NULL
to	NULL
the	NULL
control	NULL
of	NULL
different	NULL
target	NULL
genes	NULL
might	NULL
be	NULL
the	NULL
cooperation	NULL
of	NULL
NF-AT	NULL
factors	NULL
with	NULL
specific	NULL
transcriptional	NULL
activators	NULL
and	NULL
repressors	NULL
,	NULL
resulting	NULL
in	NULL
diverging	NULL
transcriptional	NULL
responses	NULL
.	NULL

To	NULL
elucidate	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
NF-ATe	NULL
proteins	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
transcriptional	NULL
function	NULL
of	NULL
C-terminal	NULL
peptides	NULL
of	NULL
two	NULL
NF-ATc	NULL
isoforms	NULL
.	NULL

Like	NULL
other	NULL
NF-AT	NULL
factors	NULL
,	NULL
NF-ATc	NULL
is	NULL
expressed	NULL
in	NULL
multiple	NULL
isoforms	NULL
(	NULL
17	NULL
)	NULL
.	NULL

This	NULL
is	NULL
due	NULL
to	NULL
alternate	NULL
splice/polyadenylation	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
predominant	NULL
synthesis	NULL
of	NULL
the	NULL
longer	NULL
NF-ATc	NULL
isoforms	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
shorter	NULL
isoform	NULL
,	NULL
A	NULL
,	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

Isoforms	NULL
B	NULL
and	NULL
C	NULL
mainly	NULL
differ	NULL
from	NULL
isoform	NULL
A	NULL
in	NULL
the	NULL
length	NULL
of	NULL
their	NULL
C	NULL
termini	NULL
.	NULL

While	NULL
isoform	NULL
B	NULL
spans	NULL
an	NULL
additional	NULL
stretch	NULL
of	NULL
128	NULL
aa	NULL
,	NULL
isoform	NULL
C	NULL
contains	NULL
this	NULL
peptide	NULL
and	NULL
an	NULL
extra	NULL
stretch	NULL
of	NULL
118	NULL
aa	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
will	NULL
show	NULL
here	NULL
that	NULL
the	NULL
246-aa	NULL
C-terminal	NULL
peptide	NULL
of	NULL
isoform	NULL
C	NULL
spans	NULL
a	NULL
frans-activation	NULL
domain	NULL
,	NULL
TAD-B	NULL
,	NULL
``	NULL
which	NULL
along	NULL
with	NULL
the	NULL
common	NULL
N-terminal	NULL
TAD-A	NULL
controls	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-ATe/C	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
C-terminal	NULL
peptide	NULL
in	NULL
NF-ATc/B	NULL
appears	NULL
to	NULL
act	NULL
like	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

We	NULL
assume	NULL
that	NULL
these	NULL
properties	NULL
of	NULL
NF-ATc	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
modulate	NULL
their	NULL
transcriptional	NULL
activity	NULL
in	NULL
naive	NULL
and	NULL
other	NULL
T	NULL
cells	NULL
where	NULL
they	NULL
are	NULL
expressed	NULL
in	NULL
high	NULL
concentrations	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
,	NULL
DNA	NULL
transfections	NULL
,	NULL
and	NULL
ELISAs	NULL
All	NULL
lymphoid	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

In	NULL
transient	NULL
transfections	NULL
of	NULL
murine	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
was	NULL
transfected	NULL
into	NULL
2.5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
using	NULL
a	NULL
conventional	NULL
DEAE-dextran	NULL
transfection	NULL
protocol	NULL
.	NULL

They	NULL
were	NULL
induced	NULL
with	NULL
TPA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
TPA	NULL
plus	NULL
ionomycin	NULL
(	NULL
T+1	NULL
,	NULL
or	NULL
T+I	NULL
and	NULL
forskolin	NULL
(	NULL
5	NULL
M	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Human	NULL
293	NULL
embryonic	NULL
kidney	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Eight	NULL
to	NULL
sixteen	NULL
hours	NULL
before	NULL
transfection	NULL
the	NULL
cells	NULL
were	NULL
diluted	NULL
to	NULL
2	NULL
X	NULL
10°	NULL
cells/2-ml	NULL
dish	NULL
.	NULL

They	NULL
were	NULL
transfected	NULL
using	NULL
a	NULL
conventional	NULL
Ca**	NULL
phosphate	NULL
transfection	NULL
protocol	NULL
and	NULL
induced	NULL
with	NULL
TPA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
T+1	NULL
,	NULL
or	NULL
T+I	NULL
and	NULL
forskolin	NULL
.	NULL

Human	NULL
umbilical	NULL
cord	NULL
blood	NULL
(	NULL
CB	NULL
)	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
and	NULL
induced	NULL
with	NULL
either	NULL
T+I	NULL
or	NULL
mAbs	NULL
against	NULL
CD3	NULL
(	NULL
«	NULL
-T-Pan.Cells	NULL
,	NULL
clone	NULL
4B5	NULL
,	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
CD28	NULL
(	NULL
CLB-CD28	NULL
,	NULL
clone	NULL
1568	NULL
;	NULL
CLB	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
.	NULL

For	NULL
«	NULL
-CD3	NULL
and	NULL
CD28	NULL
Ab	NULL
stimula-tion	NULL
,	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
panned	NULL
«	NULL
-CD3	NULL
(	NULL
3	NULL
pg/ml	NULL
)	NULL
and	NULL
to	NULL
soluble	NULL
«	NULL
-CD28	NULL
Ab	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

The	NULL
secretion	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
was	NULL
determined	NULL
by	NULL
ELISAs	NULL
using	NULL
Cy-toscreen	NULL
immunoassay	NULL
kits	NULL
(	NULL
BioSource	NULL
International	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
of	NULL
NF-ATc	NULL
cDNAs	NULL
The	NULL
NF-ATe	NULL
cDNA	NULL
expression	NULL
vectors	NULL
pRSV-NF-ATc/A	NULL
and	NULL
pRSV-NF-ATc/B	NULL
were	NULL
constructed	NULL
by	NULL
the	NULL
insertion	NULL
of	NULL
complete	NULL
cDNAs	NULL
into	NULL
the	NULL
multiple	NULL
cloning	NULL
site	NULL
of	NULL
a	NULL
pBluescript	NULL
KS*	NULL
vector	NULL
containing	NULL
RSV	NULL
LTR	NULL
and	NULL
SV40	NULL
splice/poly	NULL
(	NULL
A	NULL
)	NULL
fragments	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
very	NULL
poor	NULL
expression	NULL
of	NULL
the	NULL
original	NULL
expression	NULL
vector	NULL
pRSV-NF-ATc/C	NULL
,	NULL
a	NULL
novel	NULL
expression	NULL
vector	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
Bsp681/	NULL
BamHI	NULL
fragment	NULL
in	NULL
pRSV-NF-ATc/B	NULL
with	NULL
that	NULL
of	NULL
the	NULL
original	NULL
NF-ATe/C	NULL
vector	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
pRSV	NULL
NF-ATc/C	NULL
expression	NULL
vector	NULL
used	NULL
throughout	NULL
this	NULL
work	NULL
contains	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
NF-ATc/B	NULL
and	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
NF-ATc/C	NULL
spanning	NULL
943	NULL
aa	NULL
(	NULL
instead	NULL
of	NULL
930	NULL
in	NULL
NF-ATc/C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
this	NULL
vector	NULL
allows	NULL
study	NULL
of	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
very	NULL
C-terminal	NULL
portion	NULL
of	NULL
NF-ATc/C	NULL
in	NULL
the	NULL
context	NULL
of	NULL
NF-ATc/B	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
such	NULL
an	NULL
NFE-AT	NULL
isoform	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
vivo	NULL
(	NULL
see	NULL
the	NULL
struc-	NULL
3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
TAD	NULL
,	NULL
frans-activation	NULL
domain	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoyl	NULL
12-phorbol	NULL
13-acetate	NULL
;	NULL
T+I	NULL
,	NULL
TPA	NULL
plus	NULL
ionomycin	NULL
;	NULL
CB	NULL
,	NULL
cord	NULL
blood	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltrans-ferase	NULL
;	NULL
PAA	NULL
,	NULL
polyacrylamide	NULL
;	NULL
CsA	NULL
,	NULL
cyclosporin	NULL
A	NULL
.	NULL

7295	NULL
ture	NULL
of	NULL
isoform	NULL
NF-ATe.B	NULL
described	NULL
in	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
.	NULL

For	NULL
the	NULL
activation	NULL
of	NULL
reporter	NULL
genes	NULL
,	NULL
a	NULL
2-	NULL
to	NULL
5-fold	NULL
excess	NULL
of	NULL
expression	NULL
plasmids	NULL
was	NULL
transfected	NULL
into	NULL
293	NULL
cells	NULL
along	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
promoter/luciferase	NULL
(	NULL
or	NULL
CAT	NULL
)	NULL
gene	NULL
constructs	NULL
.	NULL

RNase	NULL
protection	NULL
assays	NULL
For	NULL
RNase	NULL
protection	NULL
assays	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
TRIzol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
processed	NULL
according	NULL
to	NULL
PharMingen	NULL
's	NULL
RiboQuant	NULL
protocol	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
using	NULL
the	NULL
human	NULL
cytokine	NULL
hCK-1	NULL
multiprobe	NULL
template	NULL
set	NULL
.	NULL

Western	NULL
blot	NULL
assays	NULL
and	NULL
preparation	NULL
of	NULL
nuclear	NULL
proteins	NULL
In	NULL
Western	NULL
blot	NULL
assays	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
8	NULL
or	NULL
10	NULL
%	NULL
PAA	NULL
SDS	NULL
gels	NULL
followed	NULL
by	NULL
electrophoretic	NULL
transfer	NULL
onto	NULL
BA	NULL
85	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
overnight	NULL
and	NULL
immunodectection	NULL
with	NULL
the	NULL
NF-ATe-specific	NULL
mAb	NULL
7A6	NULL
(	NULL
19	NULL
)	NULL
,	NULL
designated	NULL
mAb-A	NULL
,	NULL
or	NULL
a	NULL
polyclonal	NULL
Ab	NULL
,	NULL
pAb-B	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
extra	NULL
C-terminal	NULL
peptide	NULL
in	NULL
NF-ATc/B	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
lymphoid	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
,	NULL
except	NULL
that	NULL
Nonidet	NULL
P-40	NULL
was	NULL
omitted	NULL
for	NULL
the	NULL
preservation	NULL
of	NULL
cell	NULL
nuclei	NULL
.	NULL

The	NULL
swollen	NULL
cells	NULL
were	NULL
disrupted	NULL
by	NULL
passing	NULL
them	NULL
10	NULL
times	NULL
through	NULL
an	NULL
injection	NULL
needle	NULL
(	NULL
26	NULL
gauge	NULL
,	NULL
0.375	NULL
in	NULL
.	NULL
)	NULL

.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
large	NULL
volumes	NULL
of	NULL
swelling	NULL
buffer	NULL
.	NULL

Immunodetections	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
enhanced	NULL
chemilumi-nescence	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Aylesbury	NULL
,	NULL
U.K.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Gal4	NULL
fusion	NULL
proteins	NULL
and	NULL
trans-activation	NULL
assays	NULL
For	NULL
determination	NULL
of	NULL
the	NULL
frans-activating	NULL
properties	NULL
of	NULL
NF-ATc	NULL
peptides	NULL
,	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
overexpression	NULL
of	NULL
Gal4/NF-ATc	NULL
fusion	NULL
proteins	NULL
were	NULL
constructed	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
RSV-LTR-controlled	NULL
Gal4	NULL
vector	NULL
pABgal	NULL
linker	NULL
(	NULL
21	NULL
)	NULL
encoding	NULL
the	NULL
1-147	NULL
aa	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
Gal4	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
Gal4	NULL
.	NULL

The	NULL
following	NULL
vectors	NULL
were	NULL
constructed	NULL
:	NULL
Gal4/TAD-A	NULL
containing	NULL
1-205	NULL
aa	NULL
from	NULL
NF-ATc/A	NULL
,	NULL
and	NULL
a	NULL
PCR	NULL
product	NULL
encoding	NULL
the	NULL
first	NULL
301	NULL
aa	NULL
of	NULL
NF-ATc	NULL
,	NULL
cut	NULL
by	NULL
Neo	NULL
!	NULL

and	NULL
cloned	NULL
as	NULL
a	NULL
blunt	NULL
end	NULL
fragment	NULL
into	NULL
the	NULL
filled	NULL
BamHI	NULL
site	NULL
of	NULL
pABgal	NULL
linker	NULL
DNA	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
way	NULL
pGal4/TAD-B	NULL
constructs	NULL
were	NULL
obtained	NULL
by	NULL
cloning	NULL
blunt	NULL
end	NULL
PCR	NULL
products	NULL
from	NULL
NF-ATc/C	NULL
into	NULL
the	NULL
filled	NULL
BamHI	NULL
site	NULL
of	NULL
pABgal	NULL
linker	NULL
plasmid	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
constructs	NULL
Gal4/	NULL
TAD-B	NULL
(	NULL
containing	NULL
aa	NULL
690-930	NULL
)	NULL
,	NULL
Gal4/TAD-B	NULL
;	NULL
,	NULL
,	NULL
(	NULL
aa	NULL
690-812	NULL
)	NULL
,	NULL
Gal4/	NULL
TAD-B3	NULL
,	NULL
(	NULL
@	NULL
a	NULL
690-720	NULL
)	NULL
,	NULL
Gal4/TAD-By	NULL
,	NULL
,	NULL
(	NULL
aa	NULL
723-812	NULL
)	NULL
,	NULL
and	NULL
(	NULL
aa	NULL
§13-930	NULL
)	NULL
.	NULL

The	NULL
structures	NULL
of	NULL
all	NULL
plasmids	NULL
were	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

All	NULL
DNA	NULL
work	NULL
was	NULL
performed	NULL
using	NULL
enzymes	NULL
from	NULL
MBI	NULL
Fermentas	NULL
(	NULL
Vilnius	NULL
,	NULL
Lithuania	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
levels	NULL
of	NULL
Gal4/NF-ATce	NULL
fusion	NULL
proteins	NULL
in	NULL
293	NULL
and	NULL
El4	NULL
cells	NULL
were	NULL
determined	NULL
in	NULL
EMSAs	NULL
using	NULL
a	NULL
Gal4	NULL
binding	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
22	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
transacting	NULL
properties	NULL
of	NULL
C-terminal	NULL
peptides	NULL
in	NULL
yeast	NULL
cells	NULL
,	NULL
the	NULL
entire	NULL
3°	NULL
DNA	NULL
fragment	NULL
of	NULL
NF-ATc/C	NULL
and	NULL
subfragments	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
construct	NULL
pAS2-1	NULL
(	NULL
Matchmaker	NULL
two-hybrid	NULL
system	NULL
2	NULL
,	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Three	NULL
separate	NULL
yeast	NULL
colonies	NULL
(	NULL
of	NULL
strain	NULL
Y190	NULL
)	NULL
transformed	NULL
with	NULL
the	NULL
DNA	NULL
constructs	NULL
were	NULL
used	NULL
to	NULL
inoculate	NULL
5	NULL
ml	NULL
of	NULL
tryptophan	NULL
drop	NULL
out	NULL
medium	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
culture	NULL
at	NULL
30°C	NULL
,	NULL
2-ml	NULL
portions	NULL
were	NULL
used	NULL
to	NULL
inoculate	NULL
5	NULL
ml	NULL
of	NULL
YPD	NULL
medium	NULL
(	NULL
Clontech	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
3-5	NULL
h	NULL
to	NULL
an	NULL
ODe	NULL
,	NULL
,	NULL
of	NULL
0.5-0.8	NULL
.	NULL

After	NULL
centrifugation	NULL
of	NULL
1.5	NULL
ml	NULL
,	NULL
the	NULL
pelleted	NULL
yeast	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
300	NULL
pl	NULL
in	NULL
buffer	NULL
Z	NULL
(	NULL
100	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
40mM	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
10mM	NULL
KCI	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
MgSO	NULL
,	NULL
,	NULL
pH	NULL
7	NULL
)	NULL
.	NULL

One	NULL
hundred	NULL
microliters	NULL
of	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
freezing	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
thawing	NULL
.	NULL

Buffer	NULL
Z	NULL
with	NULL
2-ME	NULL
(	NULL
0.7	NULL
ml	NULL
)	NULL
,	NULL
160	NULL
l	NULL
O-nitrophenyl	NULL
B-	NULL
»	NULL
-galactopyranoside	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
cultured	NULL
at	NULL
30°C	NULL
.	NULL

After	NULL
the	NULL
yellow	NULL
color	NULL
developed	NULL
,	NULL
0.4	NULL
ml	NULL
of	NULL
1	NULL
M	NULL
Na	NULL
,	NULL
CO	NULL
;	NULL
,	NULL
was	NULL
added	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
used	NULL
for	NULL
the	NULL
OD	NULL
,	NULL
,	NULL
,	NULL
measurements	NULL
.	NULL

The	NULL
B-galactosidase	NULL
units	NULL
were	NULL
calculated	NULL
according	NULL
the	NULL
formula	NULL
:	NULL
B-galactosidase	NULL
units	NULL
=	NULL
1000	NULL
X	NULL
OD	NULL
,	NULL
,	NULL
/	NULL
(	NULL
¢	NULL
X	NULL
V	NULL
X	NULL
ODg	NULL
,	NULL
,	NULL
)	NULL
,	NULL
where	NULL
f	NULL
is	NULL
the	NULL
elapsed	NULL
time	NULL
of	NULL
incubation	NULL
in	NULL
minutes	NULL
,	NULL
V	NULL
is	NULL
0.1	NULL
ml	NULL
X	NULL
concentration	NULL
factor	NULL
,	NULL
and	NULL
ODeop	NULL
is	NULL
Agop	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
culture	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7296	NULL
TRANS-ACTIVATION	NULL
BY	NULL
NF-ATce	NULL
ISOFORMS	NULL
A	NULL
_	NULL
cB-ts	NULL
,	NULL
__PBL-Ts	NULL
__	NULL
,	NULL
B	NULL
.	NULL

C	NULL
I	NULL
I	NULL
Tal	NULL
T+I	NULL
__	NULL
CD3+CD28	NULL
``	NULL
``	NULL
*	NULL
T	NULL
o	NULL
uce	NULL
T+l	NULL
ppp	NULL
``	NULL
-	NULL
6h	NULL
12h	NULL
``	NULL
-	NULL
'oh	NULL
6h	NULL
12h	NULL
2h	NULL
6h	NULL
12h	NULL
g	NULL
N	NULL
its	NULL
-	NULL
'oh	NULL
gh	NULL
12h	NULL
|	NULL
0.1	NULL
£	NULL
(	NULL
0	NULL
O	NULL
IL-5	NULL
|	NULL
rge	NULL
%	NULL
-	NULL
c	NULL
IL-4	NULL
»	NULL
|	NULL
fol	NULL
E	NULL
ch	NULL
|	NULL
<	NULL
8	NULL
|	NULL
*	NULL
‘	NULL
O	NULL
tA	NULL
|	NULL
s	NULL
o.0s	NULL
|	NULL
O	NULL
IL-10	NULL
»	NULL
||	NULL
1°	NULL
2	NULL
30	NULL
4	NULL
|	NULL
CD3+CD28	NULL
pore	NULL
a	NULL
-	NULL
'	NULL
2h	NULL
eh	NULL
12h	NULL
(	NULL
0	NULL
)	NULL
50	NULL
il	NULL
-	NULL
@	NULL
#	NULL
E3	NULL
IL-2	NULL
»	NULL
|	NULL
m	NULL
fra	NULL
<	NULL
A	NULL
A.	NULL
a	NULL
.	NULL

1	NULL
2	NULL
304	NULL
IFN-y-1.5	NULL
T+l	NULL
``	NULL
18	NULL
it-2	NULL
mg	NULL
H	NULL
i114	NULL
--	NULL
2h	NULL
6h	NULL
12h	NULL
14	NULL
u	NULL
&	NULL
C	NULL
g	NULL
gie	NULL
~=	NULL
'	NULL
16	NULL
%	NULL
®	NULL
m	NULL
lu	NULL
cud	NULL
A	NULL
C-	NULL
|	NULL
8	NULL
os-	NULL
a.	NULL
a	NULL
.	NULL

1	NULL
2	NULL
304	NULL
102	NULL
s	NULL
a	NULL
s	NULL
6	NULL
r	NULL
8	NULL
910	NULL
o	NULL
¢	NULL
-*	NULL
»	NULL
«	NULL
°	NULL
“	NULL
56	NULL
o_	NULL
$	NULL
FIGURE	NULL
1	NULL
.	NULL

Lymphokine	NULL
synthesis	NULL
and	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-ATc	NULL
isoforms	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
either	NULL
left	NULL
uninduced	NULL
or	NULL
were	NULL
induced	NULL
for	NULL
2-12	NULL
h	NULL
with	NULL
T+1	NULL
or	NULL
«	NULL
CD3	NULL
and	NULL
CD28	NULL
Abs	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
,	NULL
Induction	NULL
of	NULL
lymphokine	NULL
RNAs	NULL
in	NULL
umbilical	NULL
CB	NULL
T	NULL
cells	NULL
(	NULL
CB-T	NULL
's	NULL
)	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
(	NULL
PBL-Ts	NULL
)	NULL
.	NULL

The	NULL
RNAs	NULL
of	NULL
CB-T	NULL
cells	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
and	NULL
PBL	NULL
-T	NULL
cells	NULL
(	NULL
lanes	NULL
4-10	NULL
)	NULL
were	NULL
isolated	NULL
and	NULL
assayed	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
lymphokine	NULL
RNAs	NULL
using	NULL
the	NULL
RiboQuant	NULL
RNase	NULL
protection	NULL
kit	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
lymphokine	NULL
RNAs	NULL
is	NULL
indicated	NULL
.	NULL

C	NULL
corresponds	NULL
to	NULL
the	NULL
hL32	NULL
control	NULL
RNA	NULL
.	NULL

B	NULL
,	NULL
IL-2	NULL
and	NULL
IL-4	NULL
secretion	NULL
of	NULL
CB-T	NULL
and	NULL
PBL	NULL
-T	NULL
cells	NULL
.	NULL

Lymphokine	NULL
secretion	NULL
of	NULL
T	NULL
cells	NULL
used	NULL
for	NULL
the	NULL
RNA	NULL
protection	NULL
analyses	NULL
(	NULL
in	NULL
A	NULL
)	NULL
was	NULL
measured	NULL
in	NULL
IL-2	NULL
and	NULL
IL-4	NULL
immunoassays	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Shown	NULL
are	NULL
representative	NULL
experiments	NULL
from	NULL
more	NULL
than	NULL
two	NULL
assays	NULL
.	NULL

In	NULL
C	NULL
the	NULL
nuclear	NULL
proteins	NULL
of	NULL
T	NULL
cells	NULL
were	NULL
electrophoretically	NULL
separated	NULL
and	NULL
immunoblotted	NULL
using	NULL
the	NULL
NF-ATe-specific	NULL
mAb-A	NULL
.	NULL

The	NULL
NF-ATc	NULL
isoforms	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
are	NULL
indicated	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Lymphokine	NULL
synthesis	NULL
and	NULL
the	NULL
nuclear	NULL
occurrence	NULL
of	NULL
NF-ATc	NULL
isoforms	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
IL-2	NULL
is	NULL
the	NULL
first	NULL
lymphokine	NULL
synthesized	NULL
after	NULL
stimulation	NULL
of	NULL
naive	NULL
T	NULL
lymphocytes	NULL
from	NULL
human	NULL
CB	NULL
(	NULL
23	NULL
)	NULL
.	NULL

This	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
where	NULL
the	NULL
synthesis	NULL
of	NULL
IL-2	NULL
RNA	NULL
and	NULL
secretion	NULL
of	NULL
IL-2	NULL
were	NULL
detected	NULL
after	NULL
induction	NULL
of	NULL
CB	NULL
T	NULL
cells	NULL
by	NULL
TPA	NULL
and	NULL
ionomycin	NULL
(	NULL
T+1	NULL
)	NULL
for	NULL
6	NULL
and	NULL
12	NULL
h	NULL
,	NULL
respectively	NULL
.	NULL

Apart	NULL
from	NULL
IFN-y	NULL
and	NULL
minute	NULL
amounts	NULL
of	NULL
IL-5	NULL
,	NULL
no	NULL
further	NULL
lymphokine	NULL
RNAs	NULL
were	NULL
synthesized	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
resting	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
with	NULL
T+I	NULL
led	NULL
to	NULL
a	NULL
rapid	NULL
synthesis	NULL
of	NULL
numerous	NULL
lymphokine	NULL
RNAs	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
massive	NULL
synthesis	NULL
of	NULL
IL-2	NULL
and	NULL
IFN-y	NULL
RNAs	NULL
the	NULL
synthesis	NULL
of	NULL
Th2-type	NULL
lymphokines	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-10	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lanes	NULL
4-7	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
,	NULL
albeit	NULL
much	NULL
weaker	NULL
,	NULL
synthesis	NULL
of	NULL
lymphokine	NULL
RNAs	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
stimulation	NULL
by	NULL
«	NULL
CD3	NULL
and	NULL
CD28	NULL
Abs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

To	NULL
correlate	NULL
the	NULL
induction	NULL
of	NULL
lymphokine	NULL
synthesis	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
nuclear	NULL
NF-ATc	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
assays	NULL
using	NULL
nuclear	NULL
proteins	NULL
from	NULL
CB	NULL
and	NULL
PBL	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
mAb	NULL
raised	NULL
against	NULL
NF-ATe	NULL
for	NULL
immunodetection	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
untreated	NULL
CB	NULL
and	NULL
PBL	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
contain	NULL
any	NULL
detectable	NULL
nuclear	NULL
NF-ATc	NULL
.	NULL

Stimulation	NULL
of	NULL
CB	NULL
T	NULL
cells	NULL
with	NULL
T+I	NULL
led	NULL
to	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-A	NULL
Tc	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
after	NULL
6-12	NULL
h	NULL
,	NULL
whereas	NULL
the	NULL
same	NULL
treatment	NULL
of	NULL
PBL	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
detection	NULL
of	NULL
these	NULL
large	NULL
NF-ATc	NULL
proteins	NULL
after	NULL
2	NULL
h.	NULL
After	NULL
6	NULL
h	NULL
,	NULL
NF-ATc	NULL
isoform	NULL
A	NULL
of	NULL
about	NULL
90	NULL
kDa	NULL
became	NULL
detectable	NULL
.	NULL

A	NULL
moderate	NULL
nuclear	NULL
accumulation	NULL
of	NULL
NF-ATe	NULL
proteins	NULL
was	NULL
observed	NULL
when	NULL
PBL	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
«	NULL
CD3-CD28	NULL
Abs	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
onset	NULL
and	NULL
extent	NULL
of	NULL
lymphokine	NULL
synthesis	NULL
and	NULL
secretion	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
nuclear	NULL
appearance	NULL
of	NULL
NF-ATc	NULL
proteins	NULL
.	NULL

However	NULL
,	NULL
while	NULL
the	NULL
concentrations	NULL
of	NULL
lymphokine	NULL
RNAs	NULL
decreased	NULL
in	NULL
PBL	NULL
T	NULL
cells	NULL
after	NULL
stimulation	NULL
for	NULL
6	NULL
h	NULL
,	NULL
the	NULL
concentrations	NULL
of	NULL
nuclear	NULL
NF-ATe	NULL
proteins	NULL
in-creased	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
NF-AT	NULL
'	NULL
c	NULL
in	NULL
the	NULL
control	NULL
of	NULL
promoters	NULL
in	NULL
addition	NULL
to	NULL
those	NULL
of	NULL
lymphokine	NULL
genes	NULL
.	NULL

The	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
of	NULL
NF-ATc	NULL
isoform	NULL
C	NULL
contain	NULL
an	NULL
additional	NULL
trans-activation	NULL
domain	NULL
We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
in	NULL
numerous	NULL
types	NULL
of	NULL
T	NULL
cells	NULL
NF-ATc	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
three	NULL
isoforms	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
which	NULL
differ	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
7297	NULL
RSD	NULL
.	NULL

.	NULL

__	NULL
1	NULL
716	NULL
Relative	NULL
6000	NULL
313	NULL
Ti6	NULL
activity	NULL
%	NULL
A313-716	NULL
b	NULL
<	NULL
1	NULL
A1-108	NULL
-	NULL
c-	NULL
8-10	NULL
A120	NULL
-	NULL
100	NULL
A	NULL
a	NULL
205301	NULL
iz	NULL
113205	NULL
(	NULL
95-1007	NULL
e	NULL
TADA	NULL
1	NULL
23	NULL
4	NULL
5	NULL
6	NULL
7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
o	NULL
-	NULL
o	NULL
35004	NULL
m	NULL
TPA	NULL
®	NULL
TPA	NULL
|-	NULL
190000	NULL
RSD	NULL
L	NULL
A	NULL
NFATc/C	NULL
__	NULL
:	NULL
--	NULL
geo	NULL
2	NULL
’	NULL
41	NULL
taps	NULL
|	NULL
CB	NULL
sss	NULL
(	NULL
sg	NULL
)	NULL
]	NULL
(	NULL
*	NULL
TADByg	NULL
=_	NULL
23	NULL
f	NULL
000	NULL
TADBgg	NULL
==	NULL
___	NULL
``	NULL
[	NULL
@	NULL
a	NULL
e90	NULL
__	NULL
s12	NULL
TAD-Bq2g	NULL
1	NULL
___	NULL
Suss	NULL
)	NULL
35	NULL
1	NULL
2	NULL
s	NULL
4	NULL
5	NULL
6	NULL
7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5s	NULL
6	NULL
7	NULL
T	NULL
M	NULL
12	NULL
FZ	NULL
P¢	NULL
2.	NULL
o	NULL
p	NULL
3f	NULL
Al	NULL
A*	NULL
l	NULL
B	NULL
AD	NULL
Bpo	NULL
CPCC	NULL
*	NULL
``	NULL
£	NULL
TAD-8	NULL
30	NULL
¥	NULL
TAD-890	NULL
E	NULL
VPlIKTEPTDDYEPm	NULL
e	NULL
VABFPPJQISWA-PRPYYSQOLAMPPDPSSCL	NULL
ri	NULL
H	NULL
HHA	NULL
Hid	NULL
s	NULL
efile	NULL
fhe	NULL
s	NULL
}	NULL
evncf	NULL
fff	NULL
feeaffaf	NULL
if	NULL
+3	NULL
o	NULL
Te	NULL
aot	NULL
VPAIKTEPTDEYDPTL	NULL
I	NULL
CSPTHGGLG	NULL
-	NULL
-	NULL
SOPYYPGH	NULL
-	NULL
PMVAESPSCLVATMAPCOQFRTGL	NULL
-	NULL
$	NULL
ere	NULL
fad	NULL
1	NULL
|	NULL
E12aD2	NULL
|	NULL
100.0	NULL
mom	NULL
TAD-8	NULL
90	NULL
|	NULL
-	NULL
}	NULL
Apovso	NULL
«	NULL
nor	NULL
spaayrkovasponcmLa	NULL
Lropa	NULL
-	NULL
-ac	NULL
PPPALLPaG	NULL
s	NULL
2	NULL
|	NULL
TADB	NULL
156	NULL
efeer	NULL
eee	NULL
eee	NULL
fee	NULL
of	NULL
eee	NULL
[	NULL
for	NULL
f	NULL
{	NULL
f	NULL
oom	NULL
forge	NULL
f	NULL
frf	NULL
fae	NULL
fogs	NULL
u.	NULL
sppanvaconeaavi	NULL
yors	NULL
«	NULL
s	NULL
Lsper	NULL
Lavaor	NULL
macsoccssarinesp	NULL
|	NULL
|	NULL
<	NULL
Z	NULL
3	NULL
|	NULL
TAD	NULL
B30	NULL
|	NULL
11.6	NULL
ao	NULL
aao	NULL
amo	NULL
_	NULL
1	NULL
|	NULL
TAD-B9	NULL
%	NULL
0	NULL
|	NULL
1.2	NULL
VS	NULL
-	NULL
-	NULL
APPSS	NULL
SCPPGLEHSLC	NULL
PSSPS	NULL
-	NULL
-	NULL
PPLPPATGEPTCLOPCSPACPPATGRPGHLPSTVRRDESPTA	NULL
a	NULL
0	NULL
efor	NULL
re	NULL
of	NULL
fore	NULL
or	NULL
6	NULL
rr	NULL
afa	NULL
or	NULL
fosfpr	NULL
as	NULL
re	NULL
oof	NULL
fore	NULL
fs	NULL
g	NULL
5	NULL
|	NULL
TAD-B120	NULL
129	NULL
i	NULL
GSHOEFGHmY	NULL
IQQONATS	NULL
(	NULL
$	NULL
1—	NULL
6	NULL
|	NULL
TAD-Bpro	NULL
|	NULL
11.6	NULL
g	NULL
wo	NULL
g	NULL
I	NULL
GPRL	NULL
LPEVHEDGSPMLAP	NULL
I	NULL
[	NULL
k	NULL
1	NULL
r4	NULL
i	NULL
6	NULL
oer	NULL
|	NULL
offf	NULL
od	NULL
onf	NULL
B1	NULL
EHO	NULL
fram	NULL
f	NULL
T	NULL
EVLPAGVT	NULL
KKCOE-	NULL
QMLOOGT	NULL
I	NULL
_	NULL
FIGURE	NULL
2	NULL
.	NULL

The	NULL
C-terminal	NULL
sequences	NULL
of	NULL
NF-ATe/C	NULL
comprise	NULL
a	NULL
frans-activation	NULL
domain	NULL
,	NULL
TAD-B	NULL
.	NULL

A	NULL
,	NULL
Structure	NULL
of	NULL
chimeric	NULL
Gal4/NF-ATc	NULL
proteins	NULL
used	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
TADs	NULL
of	NULL
NF-ATc	NULL
.	NULL

The	NULL
percent	NULL
relative	NULL
activity	NULL
of	NULL
Gal4/NF-ATc	NULL
proteins	NULL
refers	NULL
to	NULL
their	NULL
activity	NULL
after	NULL
transfection	NULL
into	NULL
E4	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
TAD-A	NULL
.	NULL

B	NULL
,	NULL
Sequence	NULL
comparison	NULL
between	NULL
the	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
in	NULL
NF-ATc/B	NULL
and	NULL
C	NULL
with	NULL
those	NULL
of	NULL
NF-ATp	NULL
(	NULL
isoform	NULL
NF-AT1	NULL
C	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Identical	NULL
residues	NULL
between	NULL
the	NULL
C-terminal	NULL
peptides	NULL
in	NULL
NF-ATc	NULL
and	NULL
NF-AT1	NULL
C	NULL
(	NULL
NF-ATp	NULL
)	NULL
are	NULL
indicated	NULL
by	NULL
long	NULL
vertical	NULL
dashes	NULL
;	NULL
similar	NULL
residues	NULL
are	NULL
indicated	NULL
by	NULL
short	NULL
vertical	NULL
dashes	NULL
.	NULL

Gaps	NULL
are	NULL
indicated	NULL
by	NULL
horizontal	NULL
dashes	NULL
.	NULL

Note	NULL
the	NULL
identical	NULL
decapeptide	NULL
near	NULL
the	NULL
C	NULL
termini	NULL
of	NULL
NF-ATe/C	NULL
and	NULL
NF-AT1	NULL
C	NULL
,	NULL
which	NULL
is	NULL
boxed	NULL
.	NULL

The	NULL
peptides	NULL
encoded	NULL
by	NULL
the	NULL
various	NULL
portions	NULL
of	NULL
TAD-B	NULL
are	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
Induction	NULL
of	NULL
TAD-A	NULL
and	NULL
TAD-B	NULL
in	NULL
El4	NULL
cells	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
DNA	NULL
of	NULL
Gal4	NULL
expression	NULL
vectors	NULL
encoding	NULL
TAD-A	NULL
,	NULL
TAD-B	NULL
,	NULL
TAD-B	NULL
;	NULL
,	NULL
,	NULL
TAD-B	NULL
,	NULL
,	NULL
TAD-B	NULL
;	NULL
,	NULL
,	NULL
,	NULL
or	NULL
TAD-B	NULL
.	NULL

,	NULL
,	NULL
,	NULL
was	NULL
transfected	NULL
into	NULL
El4	NULL
cells	NULL
,	NULL
along	NULL
with	NULL
an	NULL
Elb	NULL
promoter	NULL
luciferase	NULL
construct	NULL
driven	NULL
by	NULL
four	NULL
Gal4	NULL
binding	NULL
sites	NULL
.	NULL

Twenty	NULL
hours	NULL
later	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
.	NULL

One	NULL
batch	NULL
of	NULL
cells	NULL
was	NULL
left	NULL
uninduced	NULL
,	NULL
and	NULL
one	NULL
batch	NULL
was	NULL
induced	NULL
by	NULL
TPA	NULL
for	NULL
20	NULL
h.	NULL
The	NULL
EMSAs	NULL
shown	NULL
in	NULL
the	NULL
insert	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
El4	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
corresponding	NULL
Gal4	NULL
vectors	NULL
and	NULL
induced	NULL
for	NULL
3	NULL
h	NULL
with	NULL
TPA	NULL
using	NULL
a	NULL
Gal4	NULL
DNA	NULL
binding	NULL
site	NULL
as	NULL
probe	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
from	NULL
more	NULL
than	NULL
three	NULL
transfections	NULL
is	NULL
shown	NULL
.	NULL

D	NULL
,	NULL
Induction	NULL
of	NULL
trans-acting	NULL
domains	NULL
TAD-A	NULL
and	NULL
TAD-B	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
EMSAs	NULL
of	NULL
insert	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
C	NULL
using	NULL
proteins	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
Gal4	NULL
constructs	NULL
.	NULL

£	NULL
,	NULL
Activity	NULL
of	NULL
TAD-B	NULL
in	NULL
yeast	NULL
cells	NULL
.	NULL

DNA	NULL
segments	NULL
encoding	NULL
TAD-B	NULL
,	NULL
the	NULL
TAD-B	NULL
fragments	NULL
,	NULL
or	NULL
the	NULL
TAD	NULL
of	NULL
E12	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
yeast	NULL
Gal4	NULL
vector	NULL
pAS2-1	NULL
(	NULL
Clontech	NULL
)	NULL
and	NULL
used	NULL
for	NULL
transformation	NULL
of	NULL
yeast	NULL
strain	NULL
Y190	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
TAD-B	NULL
proteins	NULL
as	NULL
determined	NULL
in	NULL
a	NULL
quantitative	NULL
lacZ	NULL
(	NULL
O-nitrophenyl	NULL
B-p-galactopyranoside	NULL
)	NULL
assay	NULL
is	NULL
compared	NULL
with	NULL
the	NULL
TAD-2	NULL
of	NULL
human	NULL
transcription	NULL
factor	NULL
E12	NULL
(	NULL
spanning	NULL
the	NULL
C-terminal	NULL
aa	NULL
378-654	NULL
)	NULL
.	NULL

in	NULL
the	NULL
length	NULL
of	NULL
their	NULL
C	NULL
termini	NULL
(	NULL
17	NULL
)	NULL
.	NULL

While	NULL
these	NULL
investigations	NULL
revealed	NULL
the	NULL
mode	NULL
of	NULL
NF-ATc	NULL
isoform	NULL
synthesis	NULL
,	NULL
they	NULL
did	NULL
not	NULL
provide	NULL
information	NULL
on	NULL
the	NULL
function	NULL
of	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
.	NULL

The	NULL
schematic	NULL
structure	NULL
of	NULL
the	NULL
NF-ATe	NULL
isoforms	NULL
A	NULL
and	NULL
C	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
.	NULL

The	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
in	NULL
NF-ATe/C	NULL
spanning	NULL
the	NULL
amino	NULL
acids	NULL
from	NULL
positions	NULL
685-930	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
exhibit	NULL
sequence	NULL
homologies	NULL
of	NULL
30.6	NULL
%	NULL
to	NULL
those	NULL
in	NULL
NF-ATp	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
more	NULL
proximal	NULL
region	NULL
(	NULL
aa	NULL
685-813	NULL
in	NULL
NF-ATe/C	NULL
)	NULL
exhibits	NULL
36.7	NULL
%	NULL
sequence	NULL
homology	NULL
.	NULL

The	NULL
NF-ATc/C-specific	NULL
domain	NULL
(	NULL
aa	NULL
814-930	NULL
)	NULL
contains	NULL
20.5	NULL
%	NULL
Pro	NULL
residues	NULL
and	NULL
shows	NULL
a	NULL
very	NULL
poor	NULL
similarity	NULL
to	NULL
NF-ATp	NULL
in	NULL
its	NULL
proximal	NULL
half	NULL
,	NULL
while	NULL
the	NULL
last	NULL
32	NULL
C-terminal	NULL
amino	NULL
acids	NULL
exhibit	NULL
a	NULL
strong	NULL
homology	NULL
to	NULL
NF-ATp	NULL
,	NULL
in	NULL
particular	NULL
to	NULL
isoform	NULL
C	NULL
(	NULL
24	NULL
)	NULL
.	NULL

They	NULL
span	NULL
an	NULL
identical	NULL
decapeptide	NULL
of	NULL
aa	NULL
911-920	NULL
(	NULL
boxed	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
that	NULL
contains	NULL
three	NULL
leucine/isoleu-cine	NULL
residues	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
could	NULL
represent	NULL
a	NULL
nuclear	NULL
export	NULL
signal	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
a	NULL
very	NULL
similar	NULL
version	NULL
it	NULL
was	NULL
identified	NULL
as	NULL
part	NULL
of	NULL
C-terminal	NULL
TAD	NULL
of	NULL
NF-ATx1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Pro-rich	NULL
peptides	NULL
occur	NULL
in	NULL
the	NULL
TADs	NULL
of	NULL
numerous	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
(	NULL
27	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
extra	NULL
C-terminal	NULL
peptides	NULL
in	NULL
the	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
contain	NULL
a	NULL
TAD	NULL
,	NULL
we	NULL
inserted	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7298	NULL
DNA	NULL
segment	NULL
encoding	NULL
all	NULL
246	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
NFATc/C	NULL
and	NULL
several	NULL
subfragments	NULL
of	NULL
them	NULL
into	NULL
a	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
encoding	NULL
the	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
Gal4	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
chimeric	NULL
Gal4/NF-ATc	NULL
proteins	NULL
expressed	NULL
from	NULL
these	NULL
constructs	NULL
was	NULL
tested	NULL
by	NULL
cotransfection	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
bearing	NULL
four	NULL
Gal4	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
transfection	NULL
resulted	NULL
in	NULL
a	NULL
pronounced	NULL
inducible	NULL
activity	NULL
of	NULL
TAD-B	NULL
,	NULL
amounting	NULL
to	NULL
approximately	NULL
15	NULL
%	NULL
that	NULL
of	NULL
TAD-A	NULL
,	NULL
ie	NULL
.	NULL

,	NULL
the	NULL
strong	NULL
N-terminal	NULL
frans-activation	NULL
domain	NULL
spanning	NULL
the	NULL
amno	NULL
acid	NULL
residues	NULL
from	NULL
113-205	NULL
in	NULL
all	NULL
NF-ATc	NULL
isoforms	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
shorter	NULL
C-terminal	NULL
peptides	NULL
,	NULL
in	NULL
particular	NULL
TAD-B	NULL
;	NULL
,	NULL
and	NULL
TAD-B	NULL
;	NULL
;	NULL
,	NULL
,	NULL
,	NULL
showed	NULL
a	NULL
mea-surable	NULL
,	NULL
albeit	NULL
weak	NULL
,	NULL
activity	NULL
in	NULL
El4	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TAD-Bop	NULL
was	NULL
completely	NULL
inactive	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
293	NULL
cells	NULL
.	NULL

While	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
TAD-B	NULL
was	NULL
as	NULL
active	NULL
as	NULL
in	NULL
E14	NULL
cells	NULL
;	NULL
all	NULL
shorter	NULL
peptides	NULL
were	NULL
found	NULL
to	NULL
be	NULL
uninducible	NULL
and	NULL
suppressed	NULL
the	NULL
weak	NULL
activity	NULL
of	NULL
Gal4	NULL
,	NULL
;	NULL
,	NULL
,	NULL
peptide	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
C-terminal	NULL
peptides	NULL
in	NULL
yeast	NULL
cells	NULL
using	NULL
a	NULL
quantitative	NULL
B-galactosidase	NULL
assay	NULL
and	NULL
the	NULL
TAD	NULL
of	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
factor	NULL
E12	NULL
for	NULL
comparison	NULL
(	NULL
probably	NULL
due	NULL
to	NULL
its	NULL
dependence	NULL
on	NULL
the	NULL
cofactor	NULL
CBP/p300	NULL
,	NULL
TAD-A	NULL
remained	NULL
inactive	NULL
in	NULL
yeast	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
TAD-B	NULL
showed	NULL
approximately	NULL
16	NULL
%	NULL
the	NULL
activity	NULL
of	NULL
E12	NULL
TAD	NULL
.	NULL

Three	NULL
shorter	NULL
peptides	NULL
,	NULL
TAD-B	NULL
;	NULL
,	NULL
,	NULL
TAD-B	NULL
;	NULL
,	NULL
,	NULL
,	NULL
,	NULL
and	NULL
TAD-B	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
exhibited	NULL
somewhat	NULL
weaker	NULL
activity	NULL
,	NULL
whereas	NULL
TAD-By	NULL
,	NULL
was	NULL
again	NULL
inactive	NULL
,	NULL
as	NULL
in	NULL
El4	NULL
T	NULL
cells	NULL
and	NULL
293	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

26	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
second	NULL
frans-acting	NULL
domain	NULL
in	NULL
NF-ATc/C	NULL
,	NULL
TAD-B	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
positively	NULL
acting	NULL
(	NULL
present	NULL
in	NULL
TAD-B	NULL
;	NULL
,	NULL
,	NULL
TAD-B	NULL
;	NULL
;	NULL
,	NULL
,	NULL
,	NULL
and	NULL
TAD-B	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
)	NULL
and	NULL
negatively	NULL
acting	NULL
elements	NULL
(	NULL
in	NULL
TAD-Bop	NULL
)	NULL
.	NULL

pro	NULL
The	NULL
activity	NULL
of	NULL
TAD-B	NULL
is	NULL
induced	NULL
by	NULL
various	NULL
stimulators	NULL
of	NULL
T	NULL
cells	NULL
The	NULL
striking	NULL
difference	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
TPA-mediated	NULL
stimulation	NULL
between	NULL
TAD-A	NULL
and	NULL
TAD-B	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
this	NULL
is	NULL
also	NULL
true	NULL
for	NULL
other	NULL
inducers	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
(	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
TPA	NULL
is	NULL
a	NULL
quite	NULL
strong	NULL
inducer	NULL
of	NULL
TAD-A	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
5-	NULL
to	NULL
10-fold	NULL
increase	NULL
in	NULL
its	NULL
activity	NULL
in	NULL
El4	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
2-	NULL
to	NULL
3-fold	NULL
increase	NULL
was	NULL
observed	NULL
for	NULL
TAD-B	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
rise	NULL
in	NULL
intracellular	NULL
Ca*	NULL
*	NULL
,	NULL
as	NULL
mediated	NULL
by	NULL
ionomycin	NULL
treat-ment	NULL
,	NULL
increased	NULL
neither	NULL
TPA-mediated	NULL
TAD-A	NULL
nor	NULL
TAD-B	NULL
induction	NULL
,	NULL
and	NULL
CsA	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
Ca	NULL
``	NULL
*	NULL
-dependent	NULL
calcineurin	NULL
activity	NULL
,	NULL
was	NULL
without	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
TADs	NULL
by	NULL
T+I	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
irradiation	NULL
of	NULL
El4	NULL
T	NULL
cells	NULL
by	NULL
UV	NULL
light	NULL
or	NULL
treatment	NULL
with	NULL
methyl	NULL
methane	NULL
sulfonate	NULL
along	NULL
with	NULL
TPA	NULL
markedly	NULL
increased	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
TADs	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

These	NULL
results	NULL
illustrate	NULL
remarkable	NULL
similarities	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
TADs	NULL
from	NULL
NF-ATc	NULL
and	NULL
suggest	NULL
a	NULL
concerted	NULL
activation	NULL
of	NULL
TAD-A	NULL
and	NULL
TAD-B	NULL
,	NULL
which	NULL
differ	NULL
remarkably	NULL
in	NULL
strength	NULL
but	NULL
not	NULL
in	NULL
mode	NULL
of	NULL
activation	NULL
.	NULL

We	NULL
will	NULL
report	NULL
elsewhere	NULL
that	NULL
TPA	NULL
treatment	NULL
mediates	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
TAD-A	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
at	NULL
Ser	NULL
``	NULL
'	NULL
(	NULL
A.	NULL
Avots	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
which	NULL
overlaps	NULL
with	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
calcineurin	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
TAD-B	NULL
is	NULL
also	NULL
phosphorylated	NULL
after	NULL
TPA	NULL
treatment	NULL
we	NULL
performed	NULL
solid	NULL
phase	NULL
protein	NULL
kinase	NULL
assays	NULL
.	NULL

In	NULL
these	NULL
assays	NULL
whole	NULL
protein	NULL
extracts	NULL
from	NULL
El4	NULL
cells	NULL
induced	NULL
by	NULL
TPA	NULL
,	NULL
UV	NULL
light	NULL
irradi-ation	NULL
,	NULL
or	NULL
both	NULL
treatments	NULL
were	NULL
used	NULL
to	NULL
phosphorylate	NULL
chimeric	NULL
GST/TAD-A	NULL
and	NULL
-B	NULL
proteins	NULL
coupled	NULL
to	NULL
glutathione	NULL
agarose	NULL
beads	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
TPA	NULL
treatment	NULL
of	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
constitutive	NULL
TAD-A	NULL
phosphorylation	NULL
,	NULL
whereas	NULL
no	NULL
phosphorylation	NULL
could	NULL
be	NULL
detected	NULL
for	NULL
TAD-B	NULL
.	NULL

UV	NULL
irradiation	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
TPA	NULL
led	NULL
to	NULL
only	NULL
a	NULL
marginal	NULL
,	NULL
if	NULL
any	NULL
,	NULL
increase	NULL
TRANS-ACTIVATION	NULL
BY	NULL
NF-ATce	NULL
ISOFORMS	NULL
25000	NULL
r	NULL
o	NULL
uv	NULL
4	NULL
|o	NULL
t	NULL
m	NULL
TuV	NULL
a	NULL
1	NULL
15000	NULL
}	NULL
m	NULL
i+CsaA	NULL
o	NULL
T	NULL
T+	NULL
CSA	NULL
A	NULL
MMS	NULL
o	NULL
TMMS	NULL
5000	NULL
Gal4-vector	NULL
TA	NULL
-	NULL
A	NULL
--	NULL
T_	NULL
UV	NULL
UvT	NULL
--	NULL
T	NULL
UV	NULL
UT	NULL
``	NULL
~8~B	NULL
)	NULL
TAD-A	NULL
TAD-B	NULL
FIGURE	NULL
3	NULL
.	NULL

Induction	NULL
of	NULL
TAD-A	NULL
and	NULL
TAD-B	NULL
activities	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
One	NULL
microgram	NULL
of	NULL
DNA	NULL
of	NULL
Gal4	NULL
expression	NULL
vectors	NULL
encoding	NULL
TAD-A	NULL
,	NULL
TAD-B	NULL
,	NULL
or	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
Gal4-vector	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
El4	NULL
cells	NULL
along	NULL
with	NULL
an	NULL
Elb	NULL
promoter/luciferase	NULL
construct	NULL
driven	NULL
by	NULL
four	NULL
Gal4	NULL
binding	NULL
sites	NULL
.	NULL

Twenty	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
irradiation	NULL
by	NULL
UV	NULL
light	NULL
(	NULL
0.1	NULL
J/cm	NULL
)	NULL
and	NULL
treatment	NULL
with	NULL
methyl	NULL
methane	NULL
sulfonate	NULL
(	NULL
MMS	NULL
;	NULL
75	NULL
ng/ml	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
2	NULL
h	NULL
)	NULL
were	NULL
performed	NULL
to	NULL
achieve	NULL
complete	NULL
stimulation	NULL
of	NULL
JNK	NULL
kinases	NULL
as	NULL
tested	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Twenty	NULL
hours	NULL
after	NULL
the	NULL
start	NULL
of	NULL
induction	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
.	NULL

One	NULL
typical	NULL
experiment	NULL
from	NULL
three	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

B	NULL
,	NULL
Solid	NULL
phase	NULL
kinase	NULL
assays	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
TAD	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
GST/TAD-A	NULL
and	NULL
TAD-B	NULL
fusion	NULL
proteins	NULL
were	NULL
coupled	NULL
to	NULL
glutathione	NULL
agarose	NULL
beads	NULL
and	NULL
incubated	NULL
with	NULL
2	NULL
ug	NULL
whole	NULL
cellular	NULL
protein	NULL
from	NULL
uninduced	NULL
El4	NULL
cells	NULL
(	NULL
-	NULL
)	NULL
,	NULL
cells	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
TPA	NULL
(	NULL
T	NULL
)	NULL
,	NULL
cells	NULL
irradiated	NULL
with	NULL
UV	NULL
light	NULL
(	NULL
UV	NULL
)	NULL
,	NULL
or	NULL
cells	NULL
induced	NULL
by	NULL
both	NULL
treatments	NULL
(	NULL
T+UV	NULL
)	NULL
.	NULL

Autoradiographs	NULL
were	NULL
exposed	NULL
for	NULL
4	NULL
h.	NULL
in	NULL
constitutive	NULL
or	NULL
TPA-mediated	NULL
TAD-A	NULL
phosphorylation	NULL
.	NULL

Both	NULL
treatments	NULL
were	NULL
without	NULL
effect	NULL
on	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
TAD-B	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

NF-ATc	NULL
isoforms	NULL
differ	NULL
in	NULL
their	NULL
transcriptional	NULL
capacity	NULL
To	NULL
test	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
individual	NULL
NF-ATe	NULL
proteins	NULL
we	NULL
cotransfected	NULL
expression	NULL
vectors	NULL
for	NULL
NF-ATe/A	NULL
,	NULL
-B	NULL
,	NULL
or	NULL
-C	NULL
together	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
promoter/reporter	NULL
gene	NULL
constructs	NULL
into	NULL
293	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
only	NULL
minor	NULL
amounts	NULL
of	NULL
endogenous	NULL
NF-ATc	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
all	NULL
three	NULL
NF-ATe	NULL
isoforms	NULL
were	NULL
properly	NULL
expressed	NULL
and	NULL
translocated	NULL
into	NULL
the	NULL
nuclei	NULL
as	NULL
proteins	NULL
of	NULL
approximately	NULL
90	NULL
,	NULL
110	NULL
,	NULL
and	NULL
140	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
nuclear	NULL
proteins	NULL
led	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
their	NULL
electrophoretic	NULL
mobility	NULL
,	NULL
indicating	NULL
phosphorylation	NULL
of	NULL
all	NULL
three	NULL
isoforms	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

All	NULL
three	NULL
NF-ATc	NULL
proteins	NULL
stimulated	NULL
the	NULL
inducible	NULL
activation	NULL
of	NULL
luciferase	NULL
reporter	NULL
genes	NULL
driven	NULL
by	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
NF-AT	NULL
site	NULL
(	NULL
Pu-b	NULL
,	NULL
)	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
or	NULL
three	NULL
copies	NULL
of	NULL
Pu-by	NULL
from	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
D	NULL
and	NULL
E	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
all	NULL
transfection	NULL
assays	NULL
,	NULL
NF-ATc/B	NULL
was	NULL
the	NULL
weakest	NULL
trans-activator	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
,	NULL
whereas	NULL
NFATc/C	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
strongest	NULL
NF-ATc	NULL
,	NULL
being	NULL
2-fold	NULL
stronger	NULL
than	NULL
NF-ATc/A	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Pu-by	NULL
and	NULL
3-fold	NULL
stronger	NULL
in	NULL
Pu-by	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
B	NULL
.	NULL

C	NULL
N	NULL
_	NULL
CP	NULL
N_	NULL
_CP	NULL
a	NULL
e	NULL
ce	NULL
ne-ate	NULL
'	NULL
a	NULL
e	NULL
c	NULL
``	NULL
ase	NULL
c	NULL
'	NULL
``	NULL
a	NULL
s	NULL
ca	NULL
s	NULL
c	NULL
'	NULL
-m	NULL
``	NULL
KD	NULL
KD	NULL
wan	NULL
*	NULL
|	NULL
4120	NULL
a-	NULL
me	NULL
~*	NULL
|	NULL
4120	NULL
a-	NULL
W	NULL
#	NULL
er	NULL
as	NULL
(	NULL
ap	NULL
®	NULL
_	NULL
4100	NULL
»	NULL
-	NULL
.	NULL

ss	NULL
21:3	NULL
:	NULL
-	NULL
-a	NULL
80	NULL
a-	NULL
mp	NULL
1	NULL
2	NULL
3	NULL
4	NULL
56	NULL
1	NULL
2	NULL
3	NULL
4	NULL
56	NULL
12	NULL
3	NULL
4	NULL
56	NULL
maAb-A	NULL
pAb-B	NULL
maAb-A	NULL
D.	NULL
E	NULL
000	NULL
-	NULL
4x	NULL
Pu-bdl	NULL
4x	NULL
Pu-	NULL
|	NULL
-	NULL
14000	NULL
2	NULL
[	NULL
n	NULL
m	NULL
TPA	NULL
110004	NULL
40000-	NULL
3x	NULL
Pu-	NULL
bBI	NULL
f	NULL
10000	NULL
al	NULL
M	NULL
Pa	NULL
be	NULL
4	NULL
&	NULL
h	NULL
4	NULL
e	NULL
(	NULL
at	NULL
C	NULL
&	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
NFE-AT	NULL
site-driven	NULL
reporter	NULL
genes	NULL
by	NULL
the	NULL
NF-ATc	NULL
isoforms	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Expression	NULL
of	NULL
NF-ATc	NULL
cDNAs	NULL
after	NULL
transfection	NULL
into	NULL
293	NULL
cells	NULL
:	NULL
Western	NULL
blots	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
expression	NULL
vectors	NULL
RSV-NF-ATc/A	NULL
,	NULL
B	NULL
,	NULL
or	NULL
C	NULL
were	NULL
transfected	NULL
into	NULL
293	NULL
cells	NULL
as	NULL
indicated	NULL
.	NULL

Twenty	NULL
hours	NULL
later	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
by	NULL
TPA	NULL
for	NULL
3	NULL
h	NULL
and	NULL
used	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
proteins	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytoplasmic	NULL
proteins	NULL
(	NULL
CP	NULL
)	NULL
were	NULL
fractionated	NULL
on	NULL
SDS-10	NULL
%	NULL
PAA	NULL
gels	NULL
followed	NULL
by	NULL
electroblotting	NULL
.	NULL

The	NULL
NF-ATc	NULL
proteins	NULL
were	NULL
immunodetected	NULL
using	NULL
mAb-A	NULL
(	NULL
4	NULL
)	NULL
,	NULL
which	NULL
reacts	NULL
with	NULL
all	NULL
three	NULL
NF-ATc	NULL
isoforms	NULL
,	NULL
or	NULL
the	NULL
polyclonal	NULL
pAb-B	NULL
specific	NULL
for	NULL
the	NULL
isoforms	NULL
B	NULL
and	NULL
C	NULL
(	NULL
B	NULL
)	NULL
.	NULL

C	NULL
,	NULL
Dephosphorylation	NULL
of	NULL
NF-ATe	NULL
isoforms	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
RSV-NF-ATc/A	NULL
(	NULL
4	NULL
)	NULL
,	NULL
RSV-NF-ATc/B	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
RSV-NF-ATc/C	NULL
(	NULL
C	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
U	NULL
of	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
Ph	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
followed	NULL
by	NULL
electrophoresis	NULL
and	NULL
Western	NULL
blotting	NULL
using	NULL
mAb-A	NULL
.	NULL

Note	NULL
the	NULL
increase	NULL
in	NULL
mobility	NULL
of	NULL
NF-ATe	NULL
proteins	NULL
,	NULL
indicating	NULL
their	NULL
previous	NULL
phosphorylation	NULL
by	NULL
an	NULL
unknown	NULL
protein	NULL
kinase	NULL
.	NULL

D	NULL
and	NULL
E	NULL
,	NULL
Trans-activation	NULL
of	NULL
luciferase	NULL
reporter	NULL
genes	NULL
controlled	NULL
by	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
NF-AT	NULL
site	NULL
of	NULL
murine	NULL
IL-2	NULL
promoter	NULL
(	NULL
Pu-b	NULL
,	NULL
)	NULL
(	NULL
2	NULL
)	NULL
or	NULL
three	NULL
copies	NULL
of	NULL
an	NULL
NF-AT	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
IL-4	NULL
promoter	NULL
(	NULL
Pu-by	NULL
)	NULL
(	NULL
29	NULL
)	NULL
by	NULL
NF-ATc	NULL
isoforms	NULL
.	NULL

DNA	NULL
,	NULL
0.5	NULL
ug	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
0.25	NULL
jg	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
of	NULL
luciferase	NULL
reporter	NULL
genes	NULL
was	NULL
cotransfected	NULL
into	NULL
293	NULL
cells	NULL
as	NULL
indicated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
RSV-NF-ATc/A	NULL
or	NULL
B	NULL
expression	NULL
plasmids	NULL
(	NULL
Zeff	NULL
)	NULL
or	NULL
RSV-NF-ATc/A	NULL
or	NULL
C	NULL
plasmids	NULL
(	NULL
right	NULL
)	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
control	NULL
as	NULL
indicated	NULL
.	NULL

Twenty	NULL
hours	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
induced	NULL
for	NULL
18	NULL
h	NULL
by	NULL
TPA	NULL
and	NULL
harvested	NULL
for	NULL
luciferase	NULL
assays	NULL
as	NULL
described	NULL
.	NULL

The	NULL
SDs	NULL
of	NULL
three	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
activities	NULL
of	NULL
individual	NULL
NF-ATc	NULL
isoforms	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
promoters	NULL
after	NULL
transfection	NULL
into	NULL
293	NULL
cells	NULL
.	NULL

To	NULL
test	NULL
the	NULL
effect	NULL
of	NULL
NF-ATe	NULL
proteins	NULL
on	NULL
the	NULL
TPA-mediated	NULL
induction	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
,	NULL
luciferase	NULL
and	NULL
CAT	NULL
reporter	NULL
gene	NULL
constructs	NULL
governed	NULL
by	NULL
either	NULL
the	NULL
IL-2	NULL
or	NULL
IL-4	NULL
promoter	NULL
were	NULL
cotransfected	NULL
with	NULL
NF-ATc	NULL
expression	NULL
vectors	NULL
into	NULL
the	NULL
same	NULL
batch	NULL
of	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
all	NULL
three	NULL
isoforms	NULL
increased	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
promoters	NULL
,	NULL
in	NULL
particular	NULL
after	NULL
stimulation	NULL
with	NULL
TPA	NULL
.	NULL

In	NULL
these	NULL
assays	NULL
,	NULL
NF-ATc/B	NULL
again	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
weakest	NULL
frans-activator	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
2-	NULL
to	NULL
5-fold	NULL
weaker	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
than	NULL
NF-ATc/A	NULL
.	NULL

7299	NULL
A	NULL
22000	NULL
IL-2	NULL
Lue	NULL
|	NULL
g	NULL
_	NULL
.	NULL

15000	NULL
-	NULL
m	NULL
TPA	NULL
3h	NULL
-	NULL
6400	NULL
12h	NULL
11000	NULL
IL-2	NULL
Luc	NULL
3	NULL
h	NULL
6000	NULL
fea	NULL
o	NULL
o	NULL
6	NULL
1	NULL
1000	NULL
95	NULL
«	NULL
&	NULL
IL-4	NULL
CAT	NULL
M	NULL
%	NULL
Acetylation	NULL
®	NULL
l=	NULL
]	NULL
l	NULL
ro	NULL
w	NULL
1	NULL
vAB	NULL
vAB	NULL
vAB	NULL
vAB	NULL
vAC	NULL
vAC	NULL
vAC	NULL
vAC	NULL
70	NULL
D	NULL
-so-	NULL
H	NULL
T	NULL
:	NULL
T	NULL
[	NULL
FQ	NULL
T+l+Forsk	NULL
f	NULL
IL-5	NULL
promoter	NULL
§	NULL
so	NULL
x	NULL
3	NULL
40	NULL
30	NULL
20	NULL
10	NULL
7	NULL
rome	NULL
NF-ATc/B	NULL
Ets-1	NULL
FIGURE	NULL
5	NULL
.	NULL

Activation	NULL
of	NULL
lymphokine	NULL
promoters	NULL
by	NULL
NF-ATc/A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Trans-activation	NULL
of	NULL
murine	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
CAT	NULL
and	NULL
0.25	NULL
pug	NULL
pf	NULL
luciferase	NULL
promoter	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
(	NULL
up	NULL
to	NULL
-293	NULL
)	NULL
(	NULL
2	NULL
)	NULL
or	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
-270	NULL
)	NULL
(	NULL
29	NULL
)	NULL
were	NULL
cotransfected	NULL
into	NULL
the	NULL
same	NULL
batch	NULL
of	NULL
293	NULL
cells	NULL
as	NULL
indicated	NULL
together	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
RSV-NF-ATc/A	NULL
and	NULL
B	NULL
(	NULL
Jeff	NULL
)	NULL
or	NULL
NF-ATc/A	NULL
and	NULL
C	NULL
constructs	NULL
(	NULL
right	NULL
)	NULL
.	NULL

v	NULL
,	NULL
Cotransfection	NULL
with	NULL
an	NULL
empty	NULL
expression	NULL
plasmid	NULL
.	NULL

Twenty	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
for	NULL
3-24	NULL
h	NULL
as	NULL
indicated	NULL
and	NULL
harvested	NULL
for	NULL
CAT	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

n.d.	NULL
,	NULL
Not	NULL
determined	NULL
.	NULL

B	NULL
,	NULL
Cooperation	NULL
of	NULL
NF-ATc	NULL
isoforms	NULL
with	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

DNA	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
of	NULL
a	NULL
luciferase	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
human	NULL
IL-5	NULL
promoter	NULL
(	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
+44	NULL
to	NULL
-507	NULL
)	NULL
(	NULL
35	NULL
)	NULL
was	NULL
transfected	NULL
either	NULL
alone	NULL
or	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
RSV-LTR	NULL
expression	NULL
vectors	NULL
encoding	NULL
GATA-3	NULL
or	NULL
Ets-1	NULL
into	NULL
293	NULL
cells	NULL
.	NULL

After	NULL
incubation	NULL
over-night	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
left	NULL
uninduced	NULL
or	NULL
were	NULL
induced	NULL
by	NULL
T+I	NULL
or	NULL
T+I	NULL
and	NULL
forskolin	NULL
for	NULL
16	NULL
h.	NULL
The	NULL
SDs	NULL
of	NULL
two	NULL
parallel	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Surprisingly	NULL
,	NULL
NF-ATc/A	NULL
exerted	NULL
the	NULL
same	NULL
or	NULL
even	NULL
a	NULL
stronger	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
promoters	NULL
as	NULL
the	NULL
longest	NULL
isoform	NULL
NFATc/C	NULL
carrying	NULL
two	NULL
TADs	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Very	NULL
similar	NULL
,	NULL
albeit	NULL
less	NULL
de-tailed	NULL
,	NULL
data	NULL
on	NULL
the	NULL
different	NULL
transcriptional	NULL
potencies	NULL
of	NULL
NF-ATc	NULL
isoforms	NULL
were	NULL
also	NULL
obtained	NULL
after	NULL
transfection	NULL
into	NULL
El4	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
differences	NULL
in	NULL
the	NULL
promoter	NULL
induction	NULL
depend	NULL
on	NULL
the	NULL
type	NULL
of	NULL
promoter	NULL
and/or	NULL
the	NULL
mode	NULL
of	NULL
stimulation	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
NF-ATc	NULL
proteins	NULL
on	NULL
the	NULL
IL-5	NULL
promoter	NULL
whose	NULL
activity	NULL
is	NULL
drastically	NULL
stimulated	NULL
by	NULL
inducers	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
forskolin	NULL
(	NULL
30	NULL
)	NULL
,	NULL
which	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
interfere	NULL
with	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
only	NULL
slightly	NULL
increase	NULL
IL-4	NULL
promoter	NULL
induction	NULL
(	NULL
31	NULL
)	NULL
.	NULL

While	NULL
NF-AT	NULL
factors	NULL
alone	NULL
are	NULL
poor	NULL
activators	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
,	NULL
they	NULL
strongly	NULL
stimulate	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7300	NULL
the	NULL
protein	NULL
kinase	NULL
A-mediated	NULL
IL-5	NULL
promoter	NULL
induction	NULL
(	NULL
S.	NULL
Klein-Hessling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
cotransfections	NULL
of	NULL
an	NULL
IL-5	NULL
promoter-driven	NULL
luciferease	NULL
gene	NULL
with	NULL
vectors	NULL
expressing	NULL
the	NULL
three	NULL
NF-ATc	NULL
isoforms	NULL
with	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
drastically	NULL
enhance	NULL
the	NULL
T+I-	NULL
and	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
the	NULL
T+1I-	NULL
and	NULL
forskolin-mediated	NULL
induction	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
no	NULL
marked	NULL
differences	NULL
among	NULL
the	NULL
three	NULL
NF-ATc	NULL
isoforms	NULL
were	NULL
detected	NULL
when	NULL
they	NULL
were	NULL
cotransfected	NULL
with	NULL
GATA-3	NULL
or	NULL
Ets-1	NULL
alone	NULL
or	NULL
upon	NULL
cotransfection	NULL
with	NULL
GATA-3	NULL
and	NULL
Ets-1	NULL
together	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
NF-ATc	NULL
isoforms	NULL
differ	NULL
in	NULL
their	NULL
transcriptional	NULL
activity	NULL
depending	NULL
on	NULL
the	NULL
promoter	NULL
context	NULL
.	NULL

Concluding	NULL
remarks	NULL
All	NULL
members	NULL
of	NULL
NF-AT	NULL
transcription	NULL
factor	NULL
family	NULL
are	NULL
expressed	NULL
in	NULL
multiple	NULL
isoforms	NULL
.	NULL

This	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
detail	NULL
for	NULL
NF-ATp	NULL
and	NULL
NF-AT4/x	NULL
,	NULL
which	NULL
are	NULL
expressed	NULL
in	NULL
several	NULL
isoforms	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
other	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
NF-ATc	NULL
isoforms	NULL
,	NULL
all	NULL
three	NULL
NF-ATp	NULL
isoforms	NULL
are	NULL
similar	NULL
in	NULL
length	NULL
or	NULL
even	NULL
longer	NULL
than	NULL
NF-ATc/C	NULL
,	NULL
the	NULL
longest	NULL
NF-ATc	NULL
isoform	NULL
.	NULL

A	NULL
short	NULL
isoform	NULL
lacking	NULL
an	NULL
extra	NULL
C-terminal	NULL
peptide	NULL
,	NULL
as	NULL
does	NULL
NF-ATc/A	NULL
,	NULL
has	NULL
also	NULL
been	NULL
described	NULL
for	NULL
NF-AT4	NULL
(	NULL
32	NULL
)	NULL
,	NULL
but	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
shown	NULL
whether	NULL
it	NULL
is	NULL
inducibly	NULL
synthesized	NULL
like	NULL
NF-ATc/A	NULL
.	NULL

The	NULL
NF-ATp	NULL
isoforms	NULL
share	NULL
a	NULL
C-terminal	NULL
QP-rich	NULL
stretch	NULL
of	NULL
approximately	NULL
220	NULL
aa	NULL
that	NULL
shows	NULL
>	NULL
30	NULL
%	NULL
homology	NULL
to	NULL
the	NULL
C-terminal	NULL
NF-ATc/C	NULL
peptide	NULL
and	NULL
is	NULL
able	NULL
to	NULL
act	NULL
as	NULL
a	NULL
TAD	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
second	NULL
TAD	NULL
has	NULL
also	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
the	NULL
longest	NULL
isoform	NULL
of	NULL
NF-AT4/x	NULL
,	NULL
designated	NULL
NFATx1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
C-terminal	NULL
TAD	NULL
is	NULL
not	NULL
a	NULL
peculiarity	NULL
of	NULL
the	NULL
long	NULL
NF-ATe	NULL
isoform	NULL
C	NULL
but	NULL
is	NULL
a	NULL
typical	NULL
component	NULL
of	NULL
numerous	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Using	NULL
a	NULL
panel	NULL
of	NULL
NF-ATe-specific	NULL
Abs	NULL
Lyakh	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
observed	NULL
in	NULL
peripheral	NULL
human	NULL
T	NULL
cells	NULL
the	NULL
expression	NULL
of	NULL
three	NULL
prominent	NULL
NF-ATe	NULL
proteins	NULL
very	NULL
similar	NULL
in	NULL
length	NULL
to	NULL
the	NULL
three	NULL
NF-ATc	NULL
isoforms	NULL
we	NULL
have	NULL
cloned	NULL
.	NULL

An	NULL
NF-ATe	NULL
isoform	NULL
similar	NULL
to	NULL
isoform	NULL
B	NULL
and	NULL
designated	NULL
NF-ATe.B	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
Burkitt	NULL
lymphoma	NULL
cDNA	NULL
library	NULL
and	NULL
described	NULL
to	NULL
posses	NULL
a	NULL
specific	NULL
C-terminal	NULL
peptide	NULL
missing	NULL
any	NULL
homology	NULL
to	NULL
NF-ATp	NULL
(	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
introduction	NULL
of	NULL
2	NULL
bp	NULL
into	NULL
the	NULL
NF-ATc.B	NULL
sequence	NULL
(	NULL
at	NULL
positions	NULL
2334	NULL
(	NULL
C	NULL
)	NULL
and	NULL
2451	NULL
(	NULL
G	NULL
)	NULL
;	NULL
numbering	NULL
according	NULL
to	NULL
Ref	NULL
.	NULL

18	NULL
)	NULL
leads	NULL
to	NULL
a	NULL
sequence	NULL
identical	NULL
to	NULL
the	NULL
NF-ATc/B	NULL
peptide	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
shares	NULL
about	NULL
36	NULL
%	NULL
sequence	NULL
homology	NULL
to	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
NF-ATp	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
TAD-B	NULL
in	NULL
NF-ATe/C	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
which	NULL
roles	NULL
these	NULL
isoforms	NULL
play	NULL
in	NULL
gene	NULL
control	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
other	NULL
cells	NULL
where	NULL
they	NULL
are	NULL
highly	NULL
expressed	NULL
at	NULL
different	NULL
relative	NULL
levels	NULL
.	NULL

The	NULL
conspicuous	NULL
differences	NULL
between	NULL
the	NULL
NF-ATc	NULL
isoforms	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
,	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
and	NULL
of	NULL
the	NULL
IL-5	NULL
promoter	NULL
,	NULL
on	NULL
the	NULL
other	NULL
,	NULL
suggest	NULL
important	NULL
functional	NULL
roles	NULL
of	NULL
individual	NULL
isoforms	NULL
in	NULL
promoter	NULL
control	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
threshold	NULL
levels	NULL
of	NULL
NF-AT	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
promoters	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
due	NULL
to	NULL
the	NULL
different	NULL
transcriptional	NULL
capacities	NULL
of	NULL
NF-AT	NULL
isoforms	NULL
,	NULL
changes	NULL
in	NULL
isoform	NULL
composition	NULL
will	NULL
result	NULL
in	NULL
marked	NULL
differences	NULL
in	NULL
specific	NULL
transcriptional	NULL
activity	NULL
of	NULL
nuclear	NULL
NF-ATe	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
NF-AT-driven	NULL
promoters	NULL
other	NULL
than	NULL
the	NULL
typical	NULL
lymphokine	NULL
promoters	NULL
,	NULL
the	NULL
establishment	NULL
of	NULL
mouse	NULL
mutants	NULL
defective	NULL
in	NULL
the	NULL
synthesis	NULL
of	NULL
one	NULL
or	NULL
the	NULL
other	NULL
NF-ATc	NULL
isoform	NULL
will	NULL
allow	NULL
study	NULL
of	NULL
the	NULL
function	NULL
of	NULL
individual	NULL
NF-ATe	NULL
proteins	NULL
in	NULL
detail	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Hona	NULL
Pictrowski	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
Dr.	NULL
Wolfgang	NULL
Haedicke	NULL
for	NULL
support	NULL
in	NULL
DNA	NULL
sequencing	NULL
.	NULL

For	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
we	NULL
thank	NULL
Stefan	NULL
Klein-Hessling	NULL
and	NULL
Anneliese	NULL
Schimpl	NULL
.	NULL

For	NULL
TRANS-ACTIVATION	NULL
BY	NULL
NF-ATce	NULL
ISOFORMS	NULL
gifts	NULL
of	NULL
materials	NULL
,	NULL
we	NULL
are	NULL
indebted	NULL
to	NULL
Drs	NULL
.	NULL

P.	NULL
Matthias	NULL
(	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
,	NULL
A.	NULL
Rao	NULL
(	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
L.	NULL
Schmitz	NULL
(	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
Th	NULL
.	NULL

Wirth	NULL
(	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

A.A.	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
and	NULL
LI	NULL
.	NULL

thank	NULL
Prof.	NULL
E.	NULL
Grens	NULL
(	NULL
Riga	NULL
,	NULL
Latvia	NULL
)	NULL
for	NULL
continuous	NULL
support	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Shaw	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emme	NULL
]	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202	NULL
.	NULL

2	NULL
.	NULL

Randak	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
M.	NULL
Hergenrother	NULL
,	NULL
I.	NULL
Sobotta	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1990	NULL
.	NULL

Cyclosporin	NULL
A	NULL
suppresses	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
lymphocyte-specific	NULL
factors	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2529	NULL
.	NULL

3	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299	NULL
.	NULL

4	NULL
.	NULL

Rao	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
:	NULL
regulation	NULL
and	NULL
function	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:707	NULL
.	NULL

5	NULL
.	NULL

Kel	NULL
,	NULL
A.	NULL
,	NULL
O.	NULL
Kel-Margoulis	NULL
,	NULL
V.	NULL
Babenko	NULL
,	NULL
and	NULL
E.	NULL
Wingender	NULL
.	NULL

1999	NULL
.	NULL

Recognition	NULL
of	NULL
NF-ATp/AP-1	NULL
composite	NULL
elements	NULL
within	NULL
genes	NULL
induced	NULL
upon	NULL
the	NULL
activation	NULL
of	NULL
immune	NULL
cells	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

288:353	NULL
.	NULL

6	NULL
.	NULL

Mages	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
R.	NULL
Baag	NULL
,	NULL
B.	NULL
Steiner	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Kroczek	NULL
.	NULL

1998	NULL
.	NULL

Utilization	NULL
of	NULL
an	NULL
NF-ATp	NULL
binding	NULL
promoter	NULL
element	NULL
for	NULL
EGR3	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
fi-broblasts	NULL
provides	NULL
a	NULL
molecular	NULL
model	NULL
for	NULL
the	NULL
lymphoid	NULL
cell-specific	NULL
effect	NULL
of	NULL
cyclosporin	NULL
A.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:7157	NULL
.	NULL

7	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA-binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138	NULL
.	NULL

8	NULL
.	NULL

Wolfe	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
P.	NULL
Zhou	NULL
,	NULL
V.	NULL
Dotsch	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
A	NULL
.	NULL

You	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
G.	NULL
Wagner	NULL
,	NULL
and	NULL
G.	NULL
L.	NULL
Verdine	NULL
.	NULL

1997	NULL
.	NULL

Unusual	NULL
Rel-like	NULL
architecture	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFATc	NULL
.	NULL

Nature	NULL
385:172	NULL
.	NULL

9.	NULL
de	NULL
la	NULL
Pompa	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
H.	NULL
Takimoto	NULL
,	NULL
H.	NULL
Yoshida	NULL
,	NULL
A.	NULL
J.	NULL
Elia	NULL
,	NULL
E.	NULL
Samper	NULL
,	NULL
J.	NULL
Potter	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
L.	NULL
Marengere	NULL
,	NULL
B.	NULL
L.	NULL
Langille	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
NF-ATc	NULL
transcription	NULL
factor	NULL
in	NULL
morphogenesis	NULL
of	NULL
cardiac	NULL
valves	NULL
and	NULL
sep-tum	NULL
.	NULL

Nature	NULL
392:182	NULL
.	NULL

10	NULL
.	NULL

Ranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
E.	NULL
M.	NULL
Gravallese	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
C.	NULL
Mickanin	NULL
,	NULL
H.	NULL
S.	NULL
Baldwin	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-ATc	NULL
is	NULL
essential	NULL
for	NULL
cardiac	NULL
valve	NULL
formation	NULL
.	NULL

Nature	NULL
392:186	NULL
.	NULL

11	NULL
.	NULL

Ranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
M.	NULL
Oukka	NULL
,	NULL
J.	NULL
Rengarajan	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1998	NULL
.	NULL

Inhibitory	NULL
function	NULL
of	NULL
two	NULL
NFAT	NULL
family	NULL
members	NULL
in	NULL
lymphoid	NULL
homeostasis	NULL
and	NULL
Th2	NULL
de-velopment	NULL
.	NULL

Immunity	NULL
9:627	NULL
.	NULL

12	NULL
.	NULL

Yoshida	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Nishina	NULL
,	NULL
H.	NULL
Takimoto	NULL
,	NULL
L.	NULL
E.	NULL
Marengere	NULL
,	NULL
A.	NULL
C.	NULL
Wakeham	NULL
,	NULL
D.	NULL
Bouchard	NULL
,	NULL
Y.	NULL
Y.	NULL
Kong	NULL
,	NULL
T.	NULL
Ohteki	NULL
,	NULL
A.	NULL
Shahinian	NULL
,	NULL
M.	NULL
Bachmann	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
NF-ATc1	NULL
regulates	NULL
lymphocyte	NULL
proliferation	NULL
and	NULL
Th2	NULL
cytokine	NULL
production	NULL
.	NULL

Immunity	NULL
8:115	NULL
.	NULL

13	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
C.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-	NULL
deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:397	NULL
.	NULL

14	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
D.	NULL
C.	NULL
Luk	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892	NULL
.	NULL

15	NULL
.	NULL

Schuh	NULL
,	NULL
K.	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
J.	NULL
Heyer	NULL
,	NULL
U.	NULL
Bommhardt	NULL
,	NULL
E.	NULL
Jankevics	NULL
,	NULL
F.	NULL
Berberich-Sicbelt	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
H.	NULL
K.	NULL
Muller-Hermelink	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1998	NULL
.	NULL

Retarded	NULL
thymic	NULL
involution	NULL
and	NULL
massive	NULL
germinal	NULL
center	NULL
formation	NULL
in	NULL
NF-	NULL
ATp-deficient	NULL
mice	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:2456	NULL
.	NULL

16	NULL
.	NULL

Kiani	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
P.	NULL
Viola	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1997	NULL
.	NULL

Down-regulation	NULL
of	NULL
IL-4	NULL
gene	NULL
transcription	NULL
and	NULL
control	NULL
of	NULL
Th2	NULL
cell	NULL
differentiation	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
NFAT1	NULL
Immunity	NULL
7:849	NULL
.	NULL

17	NULL
.	NULL

Chuvpilo	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Zimmer	NULL
,	NULL
A.	NULL
Kerstan	NULL
,	NULL
J.	NULL
Gléckner	NULL
,	NULL
A.	NULL
Avots	NULL
,	NULL
C.	NULL
Escher	NULL
,	NULL
C.	NULL
Fischer	NULL
,	NULL
I.	NULL
Inashkina	NULL
,	NULL
E.	NULL
Jankevics	NULL
,	NULL
F.	NULL
Berberich-Sicbelt	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1999	NULL
.	NULL

Alternative	NULL
polyadenylation	NULL
events	NULL
contribute	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
NF-ATc	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
10:261	NULL
.	NULL

18	NULL
.	NULL

Park	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Takeuchi	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1996	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
new	NULL
isoform	NULL
of	NULL
the	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
gene	NULL
family	NULL
member	NULL
NFAT	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:20914	NULL
.	NULL

19	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-	NULL
cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
.	NULL

20	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miiller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
lymphoid	NULL
specific	NULL
octamer	NULL
binding	NULL
protein	NULL
(	NULL
OTF-2B	NULL
)	NULL
by	NULL
proteolytic	NULL
clipping	NULL
bandshift	NULL
assay	NULL
(	NULL
PCBA	NULL
)	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4221	NULL
.	NULL

21	NULL
.	NULL

Baniahmad	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
C.	NULL
Kohne	NULL
,	NULL
and	NULL
R.	NULL
Renkawitz	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
transferable	NULL
silencing	NULL
domain	NULL
is	NULL
present	NULL
in	NULL
the	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
,	NULL
in	NULL
the	NULL
v-erbA	NULL
oncogene	NULL
product	NULL
and	NULL
in	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:1015	NULL
.	NULL

22	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
vector	NULL
,	NULL
pHisGal	NULL
,	NULL
allowing	NULL
bacterial	NULL
production	NULL
of	NULL
proteins	NULL
fused	NULL
to	NULL
a	NULL
hexahistidine-tagged	NULL
Gal4	NULL
DNA-binding	NULL
do-main	NULL
.	NULL

BioTechniques	NULL
17:714	NULL
.	NULL

23	NULL
.	NULL

Ehlers	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1991	NULL
.	NULL

Differentiation	NULL
of	NULL
T	NULL
cell	NULL
lymphokine	NULL
gene	NULL
expression	NULL
:	NULL
the	NULL
in	NULL
vitro	NULL
acquisition	NULL
of	NULL
T	NULL
cell	NULL
memory	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:25	NULL
.	NULL

24	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carew	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Recombinant	NULL
NFAT1	NULL
(	NULL
NFATp	NULL
)	NULL
is	NULL
regulated	NULL
by	NULL
calcineurin	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
mediates	NULL
transcription	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:3955	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Klemm	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
C.	NULL
R.	NULL
Beals	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabiree	NULL
.	NULL

1997	NULL
.	NULL

Rapid	NULL
targeting	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

7:638	NULL
.	NULL

Imamura	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
S.	NULL
Imai	NULL
,	NULL
T.	NULL
Fujino	NULL
,	NULL
T.	NULL
Takano	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1998	NULL
.	NULL

Carboxyl-terminal	NULL
15-amino	NULL
acid	NULL
sequence	NULL
of	NULL
NFATx1	NULL
is	NULL
possibly	NULL
created	NULL
by	NULL
tissue-specific	NULL
splicing	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
transactivation	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3455	NULL
.	NULL

Triezenberg	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
transcriptional	NULL
activation	NULL
do-mains	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

5:190	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Garcia-Cozar	NULL
,	NULL
A.	NULL
Raghavan	NULL
,	NULL
H.	NULL
Okamura	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1998	NULL
.	NULL

Selective	NULL
inhibition	NULL
of	NULL
NFAT	NULL
activation	NULL
by	NULL
a	NULL
peptide	NULL
spanning	NULL
the	NULL
calcineurin	NULL
targeting	NULL
site	NULL
of	NULL
NFAT	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
1:627	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Schomberg	NULL
,	NULL
R.	NULL
Gerwig	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
F.	NULL
Grummt	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5694	NULL
.	NULL

Lee	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
E.	NULL
S.	NULL
Masuda	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
T.	NULL
Yokota	NULL
.	NULL

1995	NULL
.	NULL

Definition	NULL
of	NULL
cis-regulatory	NULL
elements	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-5	NULL
gene	NULL
promoter	NULL
:	NULL
involvement	NULL
of	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cell-related	NULL
factors	NULL
in	NULL
interleukin-5	NULL
expression	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17541	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

7301	NULL
Neumann	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Grieshammer	NULL
,	NULL
S.	NULL
Chuypilo	NULL
,	NULL
B.	NULL
Kneitz	NULL
,	NULL
M.	NULL
Lohoff	NULL
,	NULL
A.	NULL
Schimpl	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1995	NULL
.	NULL

RelA/p65	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
for	NULL
the	NULL
immunosuppressive	NULL
action	NULL
of	NULL
protein	NULL
kinase	NULL
A.	NULL
EMBO	NULL
J	NULL
.	NULL

14:1991	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2:461	NULL
.	NULL

Luo	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

Mechanisms	NULL
of	NULL
transactivation	NULL
by	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:141	NULL
.	NULL

Lyakh	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1997	NULL
.	NULL

Expression	NULL
of	NULL
NFAT-family	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:2475	NULL
.	NULL

Gruart-Gouilleux	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Engels	NULL
,	NULL
and	NULL
M.	NULL
Sullivan	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-5	NULL
gene	NULL
promoter	NULL
:	NULL
involvement	NULL
of	NULL
octamer	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:1431	NULL
.	NULL

Ficring	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
P.	NULL
S.	NULL
Mattila	NULL
,	NULL
G.	NULL
R.	NULL
Crabiree	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1990	NULL
.	NULL

Single	NULL
cell	NULL
assay	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
reveals	NULL
a	NULL
threshold	NULL
in	NULL
transcription	NULL
activated	NULL
by	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1823	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

